{"meta":{"query_hash":"5a8ce8db8e3a","filters":{"venue":"Therapeutic Advances in Gastroenterology"},"cohort_total":83,"direct_labels_cover":0,"predictions_cover":83,"exported":83,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/5a8ce8db8e3a","api":"https://metacan.xera.ac/api/v1/cohort?venue=Therapeutic+Advances+in+Gastroenterology"},"results":[{"id":"W1584350139","doi":"10.1177/1756283x08098966","title":"Review: Current status of therapy in autoimmune liver disease","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Diseases and Immunity","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network; Toronto Western Hospital","funders":"","keywords":"Medicine; Primary sclerosing cholangitis; Autoimmune hepatitis; Azathioprine; Ursodeoxycholic acid; Liver transplantation; Primary biliary cirrhosis; Cirrhosis; Disease; Liver disease; Autoimmune disease; Gastroenterology; Internal medicine; Immunology; Transplantation","score_opus":0.02395828777097453,"score_gpt":0.33582267376770797,"score_spread":0.31186438599673344,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1584350139","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.46858054,0.53014153,0.000121471734,0.00052240875,0.0000995959,0.00045382374,0.000008382917,0.000014502239,0.000057721394],"genre_scores_gemma":[0.5677553,0.42926446,0.00005917506,0.002864187,0.000014213113,0.000015427984,0.000016256114,0.000006058647,0.000004969372],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99849695,0.00020602247,0.0004532955,0.0002208355,0.00013313215,0.0004897453],"domain_scores_gemma":[0.9992568,0.000033688906,0.0001395103,0.00039277526,0.00005002411,0.00012718294],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014556317,0.00017349837,0.0005074122,0.0001441134,0.000014857307,0.000001887242,0.00014735908,0.000027784627,0.00014180529],"category_scores_gemma":[0.000025638485,0.0001418538,0.000111690344,0.00017174461,0.00014311688,0.00014589781,0.000028104774,0.00026075757,0.00000478579],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004464755,0.0014384977,0.57062435,0.00036726295,0.00002022346,0.000024207742,0.00012549994,0.000021567585,0.00019540446,0.00010073889,0.000029548239,0.42258793],"study_design_scores_gemma":[0.003334274,0.0018280187,0.97208613,0.0012327217,0.00004780854,0.0000069169682,0.000019787709,0.000119405675,0.000014909041,0.00080090633,0.020437995,0.00007110841],"about_ca_topic_score_codex":0.00002336093,"about_ca_topic_score_gemma":0.000010674951,"teacher_disagreement_score":0.42251682,"about_ca_system_score_codex":0.000081982165,"about_ca_system_score_gemma":0.00006618582,"threshold_uncertainty_score":0.578463},"labels":[],"label_agreement":null},{"id":"W1629799475","doi":"10.1177/1756283x09357579","title":"Review: Optimal use of biologics in the management of Crohn’s disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":40,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Crohn's disease; Intensive care medicine; Disease; Inflammatory bowel disease; Biologic Agents; Internal medicine","score_opus":0.012698105401511006,"score_gpt":0.2817255603034334,"score_spread":0.26902745490192237,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1629799475","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9932021,0.005466564,0.00059717684,0.00013815798,0.00011222014,0.0004117083,0.000023285003,0.0000029469172,0.000045849374],"genre_scores_gemma":[0.98164344,0.015244194,0.0013380487,0.0016340959,0.000021545791,0.000071425326,0.000028758226,0.000009264847,0.000009233454],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988996,0.00020115194,0.00035626325,0.0002238739,0.000080413294,0.00023871168],"domain_scores_gemma":[0.99926627,0.000018259696,0.00015828245,0.0004885057,0.00003501816,0.00003364343],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003142877,0.00013127318,0.00018359972,0.000046148027,0.000012093191,0.0000023503562,0.0003648949,0.000051920506,0.000017168],"category_scores_gemma":[0.000021100916,0.00009659506,0.000075478594,0.00006389916,0.00030579043,0.000010054908,0.00009696434,0.00013196144,9.921534e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007609988,0.0009051177,0.95700943,0.0016572367,0.00013494743,0.00035132156,0.00009894216,0.0019309599,0.013256128,0.00222056,0.00013153048,0.0146938395],"study_design_scores_gemma":[0.0009786519,0.0002472991,0.98621917,0.00018151356,0.000055356122,0.000009405118,0.00005810648,0.00006459422,0.00021671211,0.0003248783,0.011548832,0.000095491254],"about_ca_topic_score_codex":0.0000016371349,"about_ca_topic_score_gemma":0.00007821606,"teacher_disagreement_score":0.029209731,"about_ca_system_score_codex":0.0000047663207,"about_ca_system_score_gemma":0.000014566029,"threshold_uncertainty_score":0.39390323},"labels":[],"label_agreement":null},{"id":"W1996479060","doi":"10.1177/1756283x09337645","title":"Review: Effect of probiotics on gastrointestinal function: evidence from animal models","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal motility and disorders","field":"Medicine","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Gastrointestinal function; Function (biology); Internal medicine; Biology; Evolutionary biology","score_opus":0.023755533960543952,"score_gpt":0.31082831028862895,"score_spread":0.287072776328085,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1996479060","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.93057495,0.03430186,0.029733181,0.0037294237,0.00011460307,0.0010871281,0.000008776185,0.00007864916,0.00037142192],"genre_scores_gemma":[0.98866457,0.002994358,0.003468264,0.004770768,0.000052908308,0.000015475167,0.000012538266,0.00001319633,0.000007934182],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981742,0.0002642502,0.00051262893,0.00041716808,0.00021216275,0.00041959333],"domain_scores_gemma":[0.9989274,0.00031113144,0.00020007338,0.00038703848,0.000079282356,0.000095038275],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00034315564,0.00027270688,0.00069904997,0.00010983094,0.000024930283,0.0000035388086,0.0001696249,0.000043113676,0.00006315569],"category_scores_gemma":[0.00019354303,0.0002197029,0.00013756557,0.0001566161,0.00020756187,0.0002121533,0.00002430888,0.00039575098,0.000010318983],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.121594876,0.0016216894,0.79673827,0.0020738812,0.00007720407,0.0001220061,0.000112654954,0.0046906453,0.011824128,0.00041227235,0.00020024038,0.06053215],"study_design_scores_gemma":[0.011617868,0.31969178,0.59856766,0.046063457,0.00087172666,0.0015687677,0.00009233531,0.008078495,0.0012405416,0.011463851,0.00034698792,0.0003965529],"about_ca_topic_score_codex":0.000007071476,"about_ca_topic_score_gemma":0.000017079377,"teacher_disagreement_score":0.31807008,"about_ca_system_score_codex":0.000057428348,"about_ca_system_score_gemma":0.00002710596,"threshold_uncertainty_score":0.8959224},"labels":[],"label_agreement":null},{"id":"W1998545651","doi":"10.1177/1756283x12473676","title":"Colonoscopy and colorectal cancer mortality: both sides of the story","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Center for Research Resources","keywords":"Medicine; Colorectal cancer; Colonoscopy; Cancer; General surgery; Internal medicine; Oncology","score_opus":0.015132518994743806,"score_gpt":0.2997473541011446,"score_spread":0.2846148351064008,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1998545651","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9938724,0.0041692224,0.00023764522,0.00082446414,0.0003061823,0.00040005022,0.0000041064704,0.000020954089,0.00016495156],"genre_scores_gemma":[0.9980773,0.00068927236,0.0001533617,0.00083830324,0.00004784488,0.00014549312,8.071592e-7,0.00001076008,0.000036887137],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9991681,0.00012256813,0.00018707632,0.00018929954,0.00011158469,0.00022134483],"domain_scores_gemma":[0.9995995,0.00006411433,0.00011240869,0.00014241133,0.00003938482,0.000042189833],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00011457502,0.00011062185,0.00027326803,0.000060519367,0.000041847215,0.000003886109,0.00007643736,0.000055212087,0.000077703204],"category_scores_gemma":[0.000016270404,0.00007789549,0.00004557754,0.00010210223,0.0003737835,0.00009775303,0.000045617322,0.00022037432,0.0000010221546],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040674563,0.0000560166,0.9627767,0.000046152105,0.00005551823,0.0000012732608,0.00024009228,0.00007110281,0.0063929795,0.00003153692,0.00001506611,0.02624606],"study_design_scores_gemma":[0.0011845578,0.0037171918,0.9900259,0.00006202328,0.000053144668,0.000039215978,0.00018344671,0.00042773705,0.003063848,0.00057170773,0.0006234658,0.000047800815],"about_ca_topic_score_codex":0.00028510846,"about_ca_topic_score_gemma":0.0021099441,"teacher_disagreement_score":0.027249115,"about_ca_system_score_codex":0.000069492125,"about_ca_system_score_gemma":0.000035320747,"threshold_uncertainty_score":0.3176486},"labels":[],"label_agreement":null},{"id":"W1999882842","doi":"10.1177/1756283x09354562","title":"Review: Efficacy and safety of tenofovir disoproxil fumarate in patients with chronic hepatitis B","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Hepatitis B Virus Studies","field":"Medicine","cited_by":56,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto Western Hospital; University of Toronto; University Health Network","funders":"","keywords":"Medicine; Adverse effect; Tenofovir; Drug; Cirrhosis; Clinical trial; Intensive care medicine; Hepatocellular carcinoma; Hepatitis B virus; Hepatitis B; Human immunodeficiency virus (HIV); Pharmacology; Internal medicine; Virology; Virus","score_opus":0.006064862638581816,"score_gpt":0.2661952676658336,"score_spread":0.2601304050272518,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1999882842","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97917616,0.019081648,0.00012883077,0.0005143594,0.000109135195,0.0008507387,0.000012821017,0.000014727548,0.00011156005],"genre_scores_gemma":[0.9424315,0.055785093,0.0004855435,0.0011746162,0.000024531473,0.000056066605,0.000013436688,0.000019784107,0.000009434049],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9986378,0.00009692282,0.00045959244,0.00029374292,0.00013840589,0.00037354548],"domain_scores_gemma":[0.9993622,0.00007249608,0.00016350693,0.00028131495,0.00006648176,0.00005403694],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019113917,0.00019164859,0.00064917404,0.000118885044,0.000025149702,0.0000017226904,0.00009386098,0.000054769785,0.000052706728],"category_scores_gemma":[0.000046850444,0.00014418938,0.000026571473,0.00014267869,0.0004516214,0.00011893912,0.000062008316,0.00035295836,0.0000032866328],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0018076899,0.00025144822,0.95306826,0.00040632914,0.000036294216,0.0000066823773,0.00008478835,0.0000047167005,0.00013343764,0.000037045178,0.000005703151,0.04415762],"study_design_scores_gemma":[0.0063326946,0.0029969374,0.98619527,0.0009475943,0.00004677495,0.000011742448,0.0000025575148,0.00002061578,0.000023400973,0.00006146656,0.0032860704,0.00007488915],"about_ca_topic_score_codex":0.00014733968,"about_ca_topic_score_gemma":0.017486501,"teacher_disagreement_score":0.04408273,"about_ca_system_score_codex":0.00006233268,"about_ca_system_score_gemma":0.000030702737,"threshold_uncertainty_score":0.9757878},"labels":[],"label_agreement":null},{"id":"W2002861309","doi":"10.1177/1756283x11405250","title":"Optimizing clinical use of mesalazine (5-aminosalicylic acid) in inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":144,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Mesalazine; Inflammatory bowel disease; Ulcerative colitis; Dosing; Clinical trial; Disease; Intensive care medicine; Internal medicine; Crohn's disease; Aminosalicylic acid; Randomized controlled trial; Gastroenterology","score_opus":0.031191929865220014,"score_gpt":0.29661892575409154,"score_spread":0.26542699588887153,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2002861309","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99593097,0.0013306364,0.002020342,0.00003282403,0.000247992,0.00030703095,0.000018119636,0.000016539154,0.00009551917],"genre_scores_gemma":[0.9956429,0.0010971588,0.0022998957,0.0007258971,0.000077390265,0.00006441932,0.000029466008,0.000038271086,0.000024624653],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9975591,0.0004975558,0.00082180864,0.0004924828,0.000120274824,0.0005087819],"domain_scores_gemma":[0.998893,0.000029837442,0.00026181727,0.00059427693,0.000056605008,0.00016443832],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00040774592,0.00025707055,0.00031776808,0.00016538057,0.000019842017,0.000005963201,0.00034880853,0.00015131466,0.00003788398],"category_scores_gemma":[0.00010196431,0.00026115554,0.00014505337,0.000066206216,0.00047313375,0.000041418258,0.00017649563,0.00021482546,0.000006366878],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.006502219,0.00035804932,0.98690754,0.00005174884,0.00004362332,0.00017639452,0.00013484652,0.0005409612,0.0031880906,0.00024012919,0.000009100087,0.001847284],"study_design_scores_gemma":[0.0023802232,0.00044302817,0.9942245,0.000043624892,0.000029599687,0.0000075625485,0.0000515334,0.0003225769,0.0007902918,0.0003742911,0.0011598613,0.00017288842],"about_ca_topic_score_codex":0.0000040228924,"about_ca_topic_score_gemma":0.00028914702,"teacher_disagreement_score":0.007316965,"about_ca_system_score_codex":0.00002302661,"about_ca_system_score_gemma":0.0000736746,"threshold_uncertainty_score":0.9999841},"labels":[],"label_agreement":null},{"id":"W2007340026","doi":"10.1177/1756283x08092548","title":"Review: Efficacy and safety of adalimumab in Crohn's disease","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Concomitant; Crohn's disease; Placebo; Internal medicine; Monoclonal antibody; Gastroenterology; Immunogenicity; Population; Tumor necrosis factor alpha; Antibody; Surgery; Disease; Immunology; Pathology","score_opus":0.008379344914020771,"score_gpt":0.26455949776942594,"score_spread":0.2561801528554052,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2007340026","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.950179,0.04887072,0.00034163424,0.00012908518,0.000056688554,0.00033117484,0.000014028597,0.000005301922,0.000072392926],"genre_scores_gemma":[0.9239369,0.07414056,0.00013572117,0.0016760874,0.000026972484,0.00003202045,0.000022105069,0.000013821034,0.000015809086],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99881935,0.0001982232,0.00034926928,0.00029007494,0.000069930335,0.00027312647],"domain_scores_gemma":[0.99947864,0.000016341231,0.00010414161,0.0002949852,0.00002704583,0.00007884091],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00014948533,0.00014790235,0.00024006676,0.000060958668,0.000022731616,0.0000010039364,0.00015329123,0.000047742014,0.000016819955],"category_scores_gemma":[0.000043467113,0.00014446097,0.000045044686,0.000053484346,0.00032543635,0.000009458275,0.00007936911,0.00008922041,0.0000015052791],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012934131,0.00032786338,0.9756802,0.00048365947,0.00003306177,0.00044185022,0.00007206371,0.0004606811,0.0018766159,0.00009530794,0.00006565451,0.0075289547],"study_design_scores_gemma":[0.002937778,0.00019363665,0.99133587,0.000202949,0.000016541044,0.000031862837,0.000009660461,0.000027453301,0.00005731437,0.00012617215,0.004968091,0.000092691604],"about_ca_topic_score_codex":0.0000019292909,"about_ca_topic_score_gemma":0.000074927295,"teacher_disagreement_score":0.026242074,"about_ca_system_score_codex":0.0000141350465,"about_ca_system_score_gemma":0.000038532606,"threshold_uncertainty_score":0.58909476},"labels":[],"label_agreement":null},{"id":"W2008468214","doi":"10.1177/1756283x10366368","title":"Review: Anti-tumor necrosis factor therapy and influenza: keeping it in perspective","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Influenza Virus Research Studies","field":"Medicine","cited_by":25,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Context (archaeology); Tumor necrosis factor alpha; Perspective (graphical); Pandemic; Intensive care medicine; Tumor necrosis factor α; Immunology; Vaccination; Coronavirus disease 2019 (COVID-19); Pathology; Disease; Infectious disease (medical specialty)","score_opus":0.06392682970734659,"score_gpt":0.4092232274303356,"score_spread":0.34529639772298903,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2008468214","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8905267,0.1039043,0.00005367584,0.003919821,0.00015936192,0.0009408228,0.000009176218,0.000035489335,0.00045063687],"genre_scores_gemma":[0.8300819,0.1260309,0.00053310057,0.043088295,0.000071245144,0.00015126404,0.0000013912748,0.000030004996,0.00001190386],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798226,0.00018045964,0.00045979038,0.00047698733,0.00019987604,0.0007006374],"domain_scores_gemma":[0.9991279,0.00016796429,0.00012531766,0.0003398099,0.00014102647,0.00009798005],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040218094,0.00027219436,0.0007507012,0.00029249422,0.00006326851,0.000010972637,0.00017552738,0.00007554299,0.00011459641],"category_scores_gemma":[0.00023867439,0.00022295257,0.00007036882,0.00023639273,0.0005925207,0.00025217194,0.00010798483,0.000906613,0.000010665746],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020273235,0.00027745983,0.95740116,0.0003267378,0.00010469669,0.000059499554,0.0016714161,0.0000047255135,0.014112388,0.00036531393,0.000038723676,0.023610556],"study_design_scores_gemma":[0.009369878,0.0020532075,0.9097195,0.001198755,0.00003800697,0.00019167642,0.0010029757,0.00010846253,0.0005262423,0.001529072,0.07397382,0.00028837053],"about_ca_topic_score_codex":0.00007730867,"about_ca_topic_score_gemma":0.00065924425,"teacher_disagreement_score":0.0739351,"about_ca_system_score_codex":0.00011406603,"about_ca_system_score_gemma":0.000045761477,"threshold_uncertainty_score":0.9091742},"labels":[],"label_agreement":null},{"id":"W2075010011","doi":"10.1177/1756283x10392443","title":"Eosinophilic colitis: epidemiology, clinical features, and current management","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":166,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"European Genomic Institute for Diabetes","keywords":"Medicine; Eosinophilic gastroenteritis; Eosinophilic esophagitis; Eosinophilia; Colitis; Eosinophilic; Immunology; Microscopic colitis; Bloody diarrhea; Abdominal pain; Diarrhea; Gastroenterology; Internal medicine; Inflammatory bowel disease; Pathology; Disease","score_opus":0.03085667099242003,"score_gpt":0.39091677512573414,"score_spread":0.36006010413331413,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2075010011","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96156013,0.0273594,0.00082105974,0.005696342,0.0020985494,0.00088992,0.000012536175,0.000103192055,0.0014588665],"genre_scores_gemma":[0.97609943,0.012301894,0.004913725,0.006087302,0.0003740493,0.00009464377,0.000020150805,0.00003102019,0.00007779343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99731815,0.00039459683,0.00077562995,0.0006613469,0.00012687719,0.00072340225],"domain_scores_gemma":[0.99861526,0.00038464725,0.00018579651,0.00054051797,0.00004090507,0.00023286509],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010333984,0.00027394822,0.0007912977,0.0001931785,0.000050817183,0.000005517639,0.00020192792,0.00019273021,0.00007438983],"category_scores_gemma":[0.00011836687,0.00024091756,0.00010495994,0.00010502684,0.0010348973,0.00011568029,0.000116066185,0.0012261376,0.000018469053],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010332592,0.0003023956,0.7272441,0.00009021765,0.000060522543,0.00008253745,0.00003653953,0.0000015258331,0.000039116956,0.008613437,0.000094640614,0.26240173],"study_design_scores_gemma":[0.0036988796,0.0010857518,0.95143193,0.000082119484,0.00009415179,0.0011217354,0.00003796558,0.000043556374,0.000007366029,0.01354931,0.028738568,0.000108692744],"about_ca_topic_score_codex":0.0000058285386,"about_ca_topic_score_gemma":0.00020995761,"teacher_disagreement_score":0.26229304,"about_ca_system_score_codex":0.000038183545,"about_ca_system_score_gemma":0.000019692088,"threshold_uncertainty_score":0.9824333},"labels":[],"label_agreement":null},{"id":"W2108127670","doi":"10.1177/1756283x10382816","title":"Exploring the role of monitoring anti-TNFα drug and antibody levels in the management of inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Crohn's disease; Adverse effect; Tumor necrosis factor alpha; Disease; Drug; Immunology; Immunogenicity; Infliximab; Internal medicine; Antibody; Intensive care medicine; Gastroenterology; Pharmacology","score_opus":0.012635517506755423,"score_gpt":0.26872174925498943,"score_spread":0.25608623174823403,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2108127670","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99793875,0.0013416492,0.00007725573,0.00006906493,0.00020002655,0.00029515414,0.0000087153185,0.000004088334,0.00006531532],"genre_scores_gemma":[0.9982607,0.0013551277,0.00014886976,0.000063130225,0.000065929904,0.0000837242,0.0000044464723,0.00001452142,0.0000035859257],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9988683,0.00017472536,0.00031796764,0.00023444706,0.00012973946,0.00027484167],"domain_scores_gemma":[0.99932677,0.000025152862,0.00013515817,0.0004476226,0.000026442098,0.00003884723],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00041624866,0.00015102273,0.00014493775,0.000062908424,0.000038169976,0.0000061206238,0.00039258486,0.000030336301,0.000002702452],"category_scores_gemma":[0.0000068471004,0.00010743667,0.00005006963,0.00005164732,0.00033463014,0.00002567407,0.00014471318,0.00017566931,4.1866326e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004867823,0.000081614606,0.9349095,0.000099073135,0.00003927881,0.00002784934,0.00038026136,0.00034565938,0.05875219,0.00058695197,1.9522952e-7,0.0042906245],"study_design_scores_gemma":[0.00067724823,0.000051477302,0.99252605,0.000044524055,0.00002567424,0.000004875804,0.0011039483,0.000054580116,0.004446334,0.00067052076,0.00032878507,0.000065983346],"about_ca_topic_score_codex":0.000003204138,"about_ca_topic_score_gemma":0.00004522152,"teacher_disagreement_score":0.057616528,"about_ca_system_score_codex":0.000005241697,"about_ca_system_score_gemma":0.00001422703,"threshold_uncertainty_score":0.43811402},"labels":[],"label_agreement":null},{"id":"W2126805615","doi":"10.1177/1756283x13502637","title":"Aflibercept in the treatment of patients with metastatic colorectal cancer: latest findings and interpretations","year":2013,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Angiogenesis and VEGF in Cancer","field":"Biochemistry, Genetics and Molecular Biology","cited_by":35,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Aflibercept; Medicine; Bevacizumab; Regorafenib; Colorectal cancer; Placental growth factor; Vascular endothelial growth factor; Angiogenesis; Oncology; Chemotherapy; Internal medicine; Cancer; Cancer research; VEGF receptors","score_opus":0.006768711707801027,"score_gpt":0.26196187607555443,"score_spread":0.2551931643677534,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2126805615","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99610275,0.0030566994,0.0002740422,0.000152115,0.00003585162,0.00033223347,0.000016880962,0.0000017130762,0.00002769978],"genre_scores_gemma":[0.9964608,0.002676188,0.00024934145,0.00028370722,0.000011754014,0.00027673782,0.000023862714,0.000008972607,0.000008618789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993579,0.00007938825,0.00016126594,0.00017239025,0.000051500676,0.00017754924],"domain_scores_gemma":[0.9997688,0.000027790042,0.000059641443,0.00009854934,0.000028345761,0.00001687007],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000039236744,0.00011139135,0.00015790714,0.00004251377,0.000019207322,0.000005213521,0.00009237242,0.000027501888,0.0000284498],"category_scores_gemma":[0.0000021926287,0.00006844404,0.000027149687,0.000056785262,0.0001723256,0.000010561313,0.000012627862,0.00003065326,6.301708e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00040266028,0.0002608211,0.983017,0.00000727062,0.000045429115,5.047698e-7,0.0008002526,0.00019000085,0.0015973287,0.000015760173,0.000005489526,0.013657429],"study_design_scores_gemma":[0.0021418135,0.004270448,0.9897422,0.00001601672,0.000034474837,0.0000039183196,0.0003698152,0.00009584344,0.0010226252,0.000117733485,0.0021069334,0.00007814289],"about_ca_topic_score_codex":0.000058127083,"about_ca_topic_score_gemma":0.0012503191,"teacher_disagreement_score":0.013579287,"about_ca_system_score_codex":0.000019511512,"about_ca_system_score_gemma":0.000010843897,"threshold_uncertainty_score":0.27910668},"labels":[],"label_agreement":null},{"id":"W2129520988","doi":"10.1177/1756283x08103341","title":"Effective treatment of chronic radiation proctitis using radiofrequency ablation","year":2009,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Optical Coherence Tomography Applications","field":"Engineering","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Cancer Institute; Natural Sciences and Engineering Research Council of Canada; National Institutes of Health; Air Force Office of Scientific Research; National Science Council","keywords":"Medicine; Argon plasma coagulation; Radiation proctitis; Radiofrequency ablation; Ablation; Ablative case; Esophagus; Proctitis; Submucosa; Endoscopy; Surgery; Radiology; Hemostasis; Coagulative necrosis; Radiation therapy; Internal medicine","score_opus":0.00808402207589402,"score_gpt":0.2718305615056287,"score_spread":0.26374653942973464,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2129520988","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82778907,0.0116486745,0.15893643,0.00005449185,0.00013810514,0.00084876706,0.0000069450384,0.00011131665,0.0004662078],"genre_scores_gemma":[0.99594486,0.0020598916,0.0018122258,0.000018048053,0.000054877786,0.00009185465,0.000006798198,0.000010469721,9.84349e-7],"study_design_codex":"design_other","study_design_gemma":"simulation_or_modeling","domain_scores_codex":[0.99927765,0.000047628313,0.00023133241,0.00014641143,0.00006049465,0.00023650672],"domain_scores_gemma":[0.9997065,0.000040966563,0.000055100023,0.00015105147,0.000019046638,0.000027340835],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00004100694,0.00012888247,0.00020928292,0.00014623476,0.000019853653,0.0000035560986,0.000072567535,0.00005121429,0.000016452565],"category_scores_gemma":[0.0000022173622,0.00012803714,0.00004446548,0.0002077843,0.00007057804,0.00019197921,0.0000021281962,0.0000622251,0.000002062406],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007614284,0.0001838189,0.020361885,0.000023303131,0.00003570027,0.000001418631,0.00020200649,0.11570973,0.015602754,0.0012142354,2.9477704e-7,0.84658873],"study_design_scores_gemma":[0.0077625667,0.016558593,0.43551135,0.00014949351,0.00023432997,0.00008885768,0.00009258489,0.4649614,0.026608331,0.04390856,0.003499816,0.0006241161],"about_ca_topic_score_codex":0.00000460165,"about_ca_topic_score_gemma":0.000023292392,"teacher_disagreement_score":0.8459646,"about_ca_system_score_codex":0.00032461213,"about_ca_system_score_gemma":0.000008701833,"threshold_uncertainty_score":0.52212024},"labels":[],"label_agreement":null},{"id":"W2136508080","doi":"10.1177/1756283x10377820","title":"Vitamin D and gastrointestinal diseases: inflammatory bowel disease and colorectal cancer","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Vitamin D Research Studies","field":"Medicine","cited_by":90,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Vitamin D and neurology; Colorectal cancer; Immune system; Disease; Cancer; Gastrointestinal cancer; vitamin D deficiency; Prostate cancer; Vitamin; Gastroenterology; Internal medicine; Immunology","score_opus":0.007395304322795506,"score_gpt":0.29648305935644353,"score_spread":0.28908775503364803,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2136508080","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9927824,0.0047610686,0.00017485405,0.0016174585,0.00013848922,0.00041254805,0.000028715453,0.00004257972,0.000041845193],"genre_scores_gemma":[0.99591786,0.0025079316,0.0006277758,0.00054056954,0.00013567737,0.00019799976,0.0000062766426,0.0000231813,0.00004273226],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99856967,0.000084744475,0.00023167502,0.00039474457,0.00017908802,0.00054009573],"domain_scores_gemma":[0.9992286,0.00013267457,0.000067735964,0.00017715694,0.00005876013,0.0003350946],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001375837,0.00021886338,0.000320048,0.00015053325,0.000079095116,0.000012876473,0.00009487702,0.00003618837,0.000046442186],"category_scores_gemma":[0.00012784346,0.0001799078,0.00003686786,0.00005940489,0.0012139712,0.00016516262,0.00015895485,0.0004661379,0.0000022841377],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019568421,0.00013198696,0.9848248,0.00017622058,0.00003996081,0.00018518753,0.000110608016,0.000007831164,0.0059175338,0.00010819038,0.000013907097,0.006526969],"study_design_scores_gemma":[0.0025369409,0.0008376612,0.99439114,0.00012344778,0.000076468794,0.00029780183,0.00014877063,0.0005199957,0.000045695902,0.0006034846,0.00033056072,0.000088036235],"about_ca_topic_score_codex":0.000007046653,"about_ca_topic_score_gemma":0.00037616445,"teacher_disagreement_score":0.009566373,"about_ca_system_score_codex":0.000038774062,"about_ca_system_score_gemma":0.000059184495,"threshold_uncertainty_score":0.73364276},"labels":[],"label_agreement":null},{"id":"W2149394302","doi":"10.1177/1756283x11398930","title":"Looking beyond symptom relief: evolution of mucosal healing in inflammatory bowel disease","year":2011,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Disease; Natural history; Crohn's disease; Ulcerative colitis; Gastroenterology; Intensive care medicine; Internal medicine","score_opus":0.006238623844901913,"score_gpt":0.23604573324984834,"score_spread":0.22980710940494642,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2149394302","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99199516,0.0032598136,0.0038933745,0.00002620942,0.00022975546,0.00026501794,0.000012323922,0.0000156038,0.00030272716],"genre_scores_gemma":[0.99863446,0.00042102474,0.00048415837,0.00026681845,0.00007260696,0.00005564123,0.000023321803,0.000030723466,0.000011232825],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982158,0.00024961864,0.0005213387,0.0004043044,0.00012695963,0.00048200806],"domain_scores_gemma":[0.9992157,0.000012665017,0.00020595152,0.0004083395,0.000049149,0.00010816222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003035765,0.00021622868,0.00020926242,0.00018965585,0.000029521616,0.0000036722447,0.00028374197,0.00011310669,0.000023937047],"category_scores_gemma":[0.000032093394,0.00023367138,0.00008568059,0.00006535049,0.00027167608,0.000027233782,0.000115351424,0.00016125622,0.000003928731],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0040409854,0.00019005037,0.986533,0.000092056536,0.00002458683,0.0000795719,0.00019178263,0.0012266078,0.0055627534,0.001178009,0.0000027795447,0.00087783264],"study_design_scores_gemma":[0.0019845713,0.00032296337,0.99205345,0.00006712502,0.000023181892,0.000009658498,0.00014690208,0.00045233488,0.00070992945,0.0038368625,0.00022820834,0.00016481674],"about_ca_topic_score_codex":0.000011738404,"about_ca_topic_score_gemma":0.00036520392,"teacher_disagreement_score":0.006639298,"about_ca_system_score_codex":0.000077584235,"about_ca_system_score_gemma":0.00009241198,"threshold_uncertainty_score":0.95288426},"labels":[],"label_agreement":null},{"id":"W2291264396","doi":"10.1177/1756283x15607414","title":"Fecal microbiota transplantation: in perspective","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":485,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Kingston General Hospital; University of Guelph; Queen's University","funders":"National Institute of Allergy and Infectious Diseases","keywords":"Fecal bacteriotherapy; Microbiome; Medicine; Clostridium difficile; Transplantation; Gut flora; Irritable bowel syndrome; Gastrointestinal tract; Inflammatory bowel disease; Feces; Dysbiosis; Immunology; Disease; Bioinformatics; Gastroenterology; Internal medicine; Biology; Microbiology; Antibiotics","score_opus":0.057922753991474306,"score_gpt":0.41139966234684777,"score_spread":0.3534769083553735,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2291264396","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011561837,0.99581164,0.000056378274,0.00025516417,0.00023002712,0.0011672797,0.000061569306,0.000030684194,0.001231094],"genre_scores_gemma":[0.0014575064,0.99756163,0.00010709146,0.00016229067,0.00019531178,0.00016548243,0.00014316068,0.0000645616,0.00014298991],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969902,0.00043455334,0.0007841676,0.00071002316,0.0002827649,0.0007983024],"domain_scores_gemma":[0.99902266,0.00013560998,0.00016580653,0.00041553713,0.000108115215,0.00015225964],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003890906,0.00049297686,0.0021832432,0.00072453724,0.000022936527,0.000011698879,0.0003029095,0.00036653556,0.00012368856],"category_scores_gemma":[0.000024539599,0.00041398127,0.00029908135,0.0005133084,0.00027824737,0.000086306514,0.0000621162,0.0012675388,0.00007641671],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002648117,0.0008281424,0.0009247701,0.008403712,0.0002002466,0.0013266937,0.0005152838,0.000012368013,0.000021235677,0.00022974893,0.000046613404,0.9848431],"study_design_scores_gemma":[0.004571677,0.0017198444,0.0001259808,0.0058809803,0.0005543476,0.0023749368,0.00038225247,0.000011991192,0.00001026895,0.00021148799,0.983848,0.00030828462],"about_ca_topic_score_codex":0.000036443736,"about_ca_topic_score_gemma":0.000343628,"teacher_disagreement_score":0.9845348,"about_ca_system_score_codex":0.0011601858,"about_ca_system_score_gemma":0.00043029373,"threshold_uncertainty_score":0.9998312},"labels":[],"label_agreement":null},{"id":"W2312759778","doi":"10.1177/1756283x16635081","title":"The role of vedolizumab in patients with moderate-to-severe Crohn’s disease and ulcerative colitis","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Crohn's disease; Internal medicine; Inflammatory bowel disease; Gastroenterology; Disease; Clinical trial","score_opus":0.005654130052781828,"score_gpt":0.25759159569248957,"score_spread":0.25193746563970776,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2312759778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09134499,0.9065949,0.00012102402,0.000018675115,0.000088286826,0.0014922263,0.00025911725,0.0000055086516,0.000075274],"genre_scores_gemma":[0.11877268,0.8805046,0.000042959007,0.00011715918,0.000045735967,0.0003728339,0.00006584497,0.00004828437,0.000029898341],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9979776,0.0004947025,0.00046064632,0.0004860046,0.00012412704,0.00045690328],"domain_scores_gemma":[0.9990658,0.00004714687,0.00025286392,0.00043627602,0.00007310664,0.00012481713],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012951138,0.00035932937,0.00063214963,0.00009664044,0.000051183484,0.000012093509,0.0003085261,0.00012243848,0.000006477624],"category_scores_gemma":[0.00002624392,0.00022162248,0.00008385489,0.000058797003,0.00033419204,0.000012274921,0.00015402836,0.00014759842,0.0000028146608],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025290003,0.00017188262,0.056027304,0.0008317434,0.00019429081,0.00004888068,0.000056387067,0.000057808087,9.942435e-7,0.0002991526,0.0000042557635,0.9170173],"study_design_scores_gemma":[0.007582294,0.0018834559,0.5357546,0.0047530164,0.00029778286,0.000017846562,0.00006823385,0.000016189404,0.000003800405,0.0020123385,0.44687968,0.0007307068],"about_ca_topic_score_codex":0.0000015500307,"about_ca_topic_score_gemma":0.00036552042,"teacher_disagreement_score":0.9162866,"about_ca_system_score_codex":0.000059397065,"about_ca_system_score_gemma":0.0001377485,"threshold_uncertainty_score":0.90375024},"labels":[],"label_agreement":null},{"id":"W2323758366","doi":"10.1177/1756283x16638833","title":"Predicting durable response or resistance to antitumor necrosis factor therapy in inflammatory bowel disease","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":83,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Medicine; Inflammatory bowel disease; Tumor necrosis factor alpha; Disease; Vedolizumab; Immunology; Intensive care medicine; Monoclonal antibody; Tumor necrosis factor α; Ulcerative colitis; Internal medicine; Infliximab; Crohn's disease; Oncology; Antibody","score_opus":0.017210947681713502,"score_gpt":0.3092586221245753,"score_spread":0.2920476744428618,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2323758366","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.15269095,0.84437674,0.00019411529,0.00011232807,0.0004357688,0.001775541,0.000337375,0.00004375615,0.00003339406],"genre_scores_gemma":[0.01255915,0.9843301,0.00014091005,0.00070077425,0.00022973424,0.0009878345,0.000057749225,0.00015671829,0.00083701574],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99473894,0.0015420385,0.0011542637,0.0011998117,0.00024862995,0.0011163416],"domain_scores_gemma":[0.9978062,0.00016653586,0.00049349136,0.0011281177,0.00007060256,0.00033505113],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006481627,0.0008029621,0.0010996262,0.00044550112,0.00008311648,0.000037947528,0.00090095954,0.0003328018,0.00008892066],"category_scores_gemma":[0.00028234965,0.0006071477,0.00032791583,0.0001882866,0.0002705072,0.000038448045,0.00025158978,0.0003732732,0.000043706026],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.22106943,0.0008592706,0.3382391,0.010408215,0.00057662505,0.0033754485,0.00034644388,0.00019275052,0.0015121792,0.00006778379,0.00024851278,0.42310426],"study_design_scores_gemma":[0.0026928922,0.0006998368,0.044310983,0.005909956,0.000059238853,0.000024379468,0.000021332065,0.0000034017942,0.000021854541,0.00008213224,0.94552886,0.0006451138],"about_ca_topic_score_codex":0.0000014756047,"about_ca_topic_score_gemma":0.00051372795,"teacher_disagreement_score":0.9452804,"about_ca_system_score_codex":0.00022955405,"about_ca_system_score_gemma":0.0005368056,"threshold_uncertainty_score":0.99963796},"labels":[],"label_agreement":null},{"id":"W2336474906","doi":"10.1177/1756283x15618130","title":"Ustekinumab for the treatment of Crohn’s disease: can it find its niche?","year":2015,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Ustekinumab; Medicine; Crohn's disease; Psoriatic arthritis; Psoriasis; Disease; Vedolizumab; Infliximab; Adalimumab; Immunology; Cohort; Secukinumab; Pharmacotherapy; Internal medicine","score_opus":0.03938787289550029,"score_gpt":0.35108627012152444,"score_spread":0.31169839722602416,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2336474906","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0009950834,0.9955255,0.00037818687,0.000086574364,0.00042175115,0.001973823,0.0005823711,0.000007404712,0.000029344947],"genre_scores_gemma":[0.0017187824,0.9955281,0.00006307624,0.00023025526,0.0002878067,0.0013294985,0.00035016978,0.00007080911,0.00042151622],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782616,0.00033153256,0.0006338849,0.0005464112,0.0001366998,0.0005253086],"domain_scores_gemma":[0.9984533,0.00008264592,0.00044391546,0.00077927153,0.00010832325,0.00013251079],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00020537591,0.0004981176,0.0009710058,0.000085657055,0.00004995416,0.000008854688,0.00054828456,0.00021076853,0.00002369749],"category_scores_gemma":[0.00003211373,0.00033655102,0.0004917033,0.00006019903,0.0002532294,0.0000053347453,0.00007271539,0.00010773861,0.000004483559],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004499904,0.00061380264,0.0010954144,0.003994608,0.00081694586,0.00010256003,0.00011710889,0.00031248483,0.000006756648,0.00008300354,0.0002788898,0.98807853],"study_design_scores_gemma":[0.0015130584,0.0009046918,0.0007754626,0.0003209149,0.0007964322,0.000016086846,0.000025957337,0.000024952955,0.0000030876715,0.00008064921,0.9953567,0.00018201675],"about_ca_topic_score_codex":0.0000017501436,"about_ca_topic_score_gemma":0.0002601472,"teacher_disagreement_score":0.9950778,"about_ca_system_score_codex":0.00013588254,"about_ca_system_score_gemma":0.0003509187,"threshold_uncertainty_score":0.9999086},"labels":[],"label_agreement":null},{"id":"W2338178060","doi":"10.1177/1756283x16637819","title":"Novel perspectives on therapeutic modulation of the gut microbiota","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":78,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"Canada Research Chairs; Canadian Celiac Association","keywords":"Gut flora; Immune system; Medicine; Disease; Inflammatory bowel disease; Immunology; Inflammation; Immune modulation; Mechanism (biology); Adverse effect; Bioinformatics; Biology; Pharmacology; Pathology","score_opus":0.021657831990492423,"score_gpt":0.32979951580502764,"score_spread":0.3081416838145352,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2338178060","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0010928607,0.9953581,0.0020444358,0.00013286024,0.00043637204,0.0007197735,0.000102378945,0.0000075173643,0.000105696774],"genre_scores_gemma":[0.03490863,0.9641074,0.00014116499,0.00038027373,0.00016953505,0.000048717317,0.000036601617,0.000056928304,0.00015075826],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99782604,0.00037157952,0.0005983072,0.00062926713,0.0001002124,0.00047459433],"domain_scores_gemma":[0.99851936,0.000048794587,0.0005603751,0.00077932107,0.000055459845,0.00003666854],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00018722916,0.0004288362,0.0008938251,0.00013932375,0.000058353904,0.0000060040256,0.0006303509,0.00035042688,0.000023902034],"category_scores_gemma":[0.000014355046,0.00025769445,0.00038145893,0.00012319758,0.0003853277,0.0000061254054,0.000147126,0.00030980576,0.000009107779],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00053511374,0.00054386357,0.0004414612,0.0020085326,0.00036056698,9.3974927e-7,0.00021782135,0.000040110233,0.10766749,0.00094836304,0.000029988963,0.8872057],"study_design_scores_gemma":[0.0012197078,0.0010702714,0.0017676475,0.0027627333,0.00013870161,0.00010604588,0.00008890437,0.0000024683984,0.00012115081,0.00017346098,0.99225926,0.00028964193],"about_ca_topic_score_codex":0.0000032555656,"about_ca_topic_score_gemma":0.000046152138,"teacher_disagreement_score":0.9922293,"about_ca_system_score_codex":0.00009672062,"about_ca_system_score_gemma":0.00010046213,"threshold_uncertainty_score":0.99998754},"labels":[],"label_agreement":null},{"id":"W2531079766","doi":"10.1177/1756283x16671670","title":"Silicone-covered biodegradable magnesium-stent insertion in the esophagus: a comparison with plastic stents","year":2016,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Magnesium Alloys: Properties and Applications","field":"Materials Science","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Waterloo","funders":"Priority Academic Program Development of Jiangsu Higher Education Institutions; National Natural Science Foundation of China; Jiangsu Provincial Clinical Orthopedic Center","keywords":"Medicine; Stent; Esophagus; Magnesium; Surgery; Silicone; Esophageal stent; Materials science","score_opus":0.016942241397172188,"score_gpt":0.25526469313301353,"score_spread":0.23832245173584135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2531079766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9903228,0.0026529017,0.0046059205,0.0016177313,0.00018375927,0.00048125186,0.000013757471,0.000038304326,0.00008355978],"genre_scores_gemma":[0.9982088,0.00016072551,0.00038591467,0.00077584025,0.000035614317,0.00035236296,0.000003506397,0.00001614727,0.00006109013],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980921,0.0002833742,0.00043992788,0.00041192357,0.00022839392,0.00054425525],"domain_scores_gemma":[0.9991684,0.00018254324,0.00017215422,0.00040103102,0.000034920726,0.000040942643],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00031156227,0.00021294868,0.0003016585,0.00010019127,0.00007980215,0.000030451472,0.00052070006,0.00005481031,0.00018655925],"category_scores_gemma":[0.000014888482,0.000105509826,0.000032413278,0.00017321766,0.00030014093,0.00031684333,0.00005722022,0.00011680639,0.000071401315],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005498013,0.0012813425,0.8204486,0.000105907195,0.000013970643,0.000022049906,0.0011435805,0.0011022077,0.15136142,0.0020353596,0.000025498419,0.016962066],"study_design_scores_gemma":[0.021293398,0.011719686,0.90915537,0.0004083902,0.0001721726,0.0003111099,0.005446024,0.0034392686,0.031311233,0.0063823047,0.009251305,0.0011097621],"about_ca_topic_score_codex":0.00007248409,"about_ca_topic_score_gemma":0.0009245761,"teacher_disagreement_score":0.120050184,"about_ca_system_score_codex":0.000078991885,"about_ca_system_score_gemma":0.000021224894,"threshold_uncertainty_score":0.43025658},"labels":[],"label_agreement":null},{"id":"W2532432536","doi":"10.1177/1756283x16674660","title":"Everolimus in the management of metastatic neuroendocrine tumours","year":2016,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Everolimus; Medicine; Pasireotide; Neuroendocrine tumors; PI3K/AKT/mTOR pathway; Temsirolimus; Oncology; Sirolimus; Internal medicine; Lanreotide; Targeted therapy; Cancer; Discovery and development of mTOR inhibitors","score_opus":0.04827955660449404,"score_gpt":0.4019686366715154,"score_spread":0.3536890800670214,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2532432536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0005346444,0.99539083,0.00011777765,0.00056416256,0.0002314491,0.002521617,0.000030417184,0.000026857277,0.0005822219],"genre_scores_gemma":[0.005685837,0.99241793,0.00044928497,0.00047417916,0.000051418836,0.00067263603,0.000019289711,0.000083396226,0.0001460288],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99498516,0.0011921293,0.0013385195,0.0007265016,0.0005918172,0.0011658681],"domain_scores_gemma":[0.9977875,0.0005431228,0.00053417555,0.0009985233,0.00004000211,0.00009671532],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000400716,0.0006179288,0.0025365117,0.00077041634,0.000025359208,0.000008315429,0.0009840566,0.000015340085,0.000088740184],"category_scores_gemma":[0.000031318374,0.00035028628,0.0003946272,0.00060890167,0.0004967269,0.00017212288,0.00023032581,0.0008706058,0.000035353467],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00092744635,0.0005877216,0.0012114659,0.018656269,0.00025719526,0.013676431,0.000023899856,0.000007671104,0.0000010117307,0.000660694,0.000013957048,0.96397626],"study_design_scores_gemma":[0.004451363,0.0026842356,0.00072292524,0.014947982,0.0008705397,0.01239427,0.00015957405,0.000003886975,0.0000033194765,0.0017333613,0.96178705,0.00024152515],"about_ca_topic_score_codex":0.0000040540986,"about_ca_topic_score_gemma":0.000041493866,"teacher_disagreement_score":0.9637347,"about_ca_system_score_codex":0.00014739404,"about_ca_system_score_gemma":0.00006846433,"threshold_uncertainty_score":0.9998949},"labels":[],"label_agreement":null},{"id":"W2592982282","doi":"10.1177/1756283x17694832","title":"Insights into the role of the intestinal microbiota in colon cancer","year":2017,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":29,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canada Research Chairs; University of New Brunswick; University of Toronto","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Colorectal cancer; Gut flora; Immune system; Microbiome; Cancer; Organoid; Mouse model of colorectal and intestinal cancer; Biology; Medicine; Cancer research; Immunology; Bioinformatics; Internal medicine; Cell biology","score_opus":0.023567496575031564,"score_gpt":0.35722175134022693,"score_spread":0.3336542547651954,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2592982282","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.012855949,0.9858228,0.000015301881,0.00012662809,0.00039860775,0.0006621269,0.000012982891,0.0000027145898,0.000102905324],"genre_scores_gemma":[0.04297926,0.9562667,0.000049562263,0.00032459025,0.0001131978,0.00014041265,0.000025760344,0.000031439256,0.00006905406],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99795634,0.0005226244,0.00060317304,0.00044519303,0.00006891519,0.0004037355],"domain_scores_gemma":[0.9984002,0.00003997455,0.0006617697,0.0008294516,0.000038901762,0.00002970897],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00019395651,0.0003381084,0.00087484147,0.00009193843,0.000099447825,0.00000991386,0.0012566056,0.0002814746,0.000010055139],"category_scores_gemma":[0.000025534524,0.00019340431,0.00022023314,0.00009903073,0.0006034705,0.000005969661,0.0003778317,0.0005349088,0.0000024539752],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00024791306,0.00014808362,0.0073847617,0.0015184337,0.00010242288,0.0000029983403,0.00032833574,0.000020135025,0.0113009615,0.00011513747,0.00002161456,0.9788092],"study_design_scores_gemma":[0.00037844066,0.00026628573,0.0010210006,0.0018552786,0.00007664572,0.000037277572,0.0000419571,0.0000025918414,0.00018543683,0.00028762707,0.9957295,0.000117961376],"about_ca_topic_score_codex":0.00014371246,"about_ca_topic_score_gemma":0.009190727,"teacher_disagreement_score":0.99570787,"about_ca_system_score_codex":0.00008378506,"about_ca_system_score_gemma":0.00026118528,"threshold_uncertainty_score":0.7886799},"labels":[],"label_agreement":null},{"id":"W2761609799","doi":"10.1177/1756283x17733657","title":"Allopurinol in combination with thiopurine induces mucosal healing and improves clinical and metabolic outcomes in IBD","year":2017,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McGill University Health Centre","funders":"","keywords":"Allopurinol; Medicine; Thiopurine methyltransferase; Pharmacology; Wound healing; Bioinformatics; Inflammatory bowel disease; Internal medicine; Surgery; Disease; Biology","score_opus":0.026669983512847686,"score_gpt":0.3637444177690611,"score_spread":0.3370744342562134,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2761609799","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99405205,0.0015148903,0.00023979665,0.0035094316,0.00009757404,0.0004946349,0.0000017565732,0.000014783023,0.00007508073],"genre_scores_gemma":[0.9943732,0.0034702665,0.0012758352,0.000739413,0.000037524096,0.000055677625,0.00000319143,0.00002063502,0.000024250789],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99820614,0.00019909837,0.00049463334,0.00042726565,0.00018657585,0.00048625938],"domain_scores_gemma":[0.99914366,0.00022113451,0.00017428146,0.0003309437,0.00003414367,0.0000958073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006223628,0.00019974586,0.00071691186,0.0002754841,0.00005939117,0.00002597764,0.00018692136,0.00011730453,0.0000038373887],"category_scores_gemma":[0.00013723361,0.00014798956,0.000024562098,0.000060253173,0.00077740144,0.00032505504,0.00017272145,0.00051413797,8.8862845e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023424625,0.0002852285,0.9584024,0.000048654223,0.000042778527,0.00009860402,0.00021537446,0.0000052732025,0.000296483,0.00033868395,3.087951e-7,0.037923757],"study_design_scores_gemma":[0.01676947,0.0016691822,0.9789082,0.00008719308,0.000025567966,0.00012666901,0.00016304775,0.00092265237,0.00009189078,0.0010573819,0.000099267614,0.00007947589],"about_ca_topic_score_codex":0.00016157913,"about_ca_topic_score_gemma":0.0018804809,"teacher_disagreement_score":0.03784428,"about_ca_system_score_codex":0.00007065321,"about_ca_system_score_gemma":0.000072142015,"threshold_uncertainty_score":0.6034839},"labels":[],"label_agreement":null},{"id":"W2790874308","doi":"10.1177/1756283x18757184","title":"The role of early colonoscopy in patients presenting with acute lower gastrointestinal bleeding: a systematic review and meta-analysis","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; Université de Sherbrooke; McGill University Health Centre","funders":"","keywords":"Medicine; Colonoscopy; Observational study; Randomized controlled trial; Odds ratio; Meta-analysis; Adverse effect; Lower gastrointestinal bleeding; Internal medicine; Incidence (geometry); Surgery; Colorectal cancer; Cancer","score_opus":0.028547339417971634,"score_gpt":0.33106797070252475,"score_spread":0.3025206312845531,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2790874308","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022802092,0.99416035,0.000036334888,0.00008461789,0.000021988222,0.0033408033,0.000028118924,0.000014266253,0.000033320695],"genre_scores_gemma":[0.009150355,0.9881054,0.0014191219,0.00012132029,0.000014235563,0.0010828149,0.000025589217,0.000049821305,0.000031337622],"study_design_codex":"observational","study_design_gemma":"meta_analysis","domain_scores_codex":[0.99633694,0.00048230408,0.0015499827,0.0006394142,0.000341281,0.00065006636],"domain_scores_gemma":[0.9971042,0.00056241656,0.0014336059,0.00058888353,0.00020423948,0.00010665013],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006437959,0.0006261918,0.0067121754,0.0003304816,0.0000584886,0.000023774763,0.0003282685,0.00007123283,0.000022059729],"category_scores_gemma":[0.00008949905,0.0003214288,0.00082940323,0.0006149834,0.00042948892,0.00010375506,0.00012815034,0.00043550032,0.000004043482],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020023712,0.0016973141,0.46463382,0.36828625,0.16181892,0.0001870537,0.000095022966,0.0000044487206,1.623269e-7,0.00008420489,0.00000514097,0.0011852767],"study_design_scores_gemma":[0.0011411929,0.011777256,0.002270515,0.05599663,0.92703295,0.0005843314,0.000026467798,0.000011417441,3.2448702e-7,0.00006009156,0.00090446585,0.00019434773],"about_ca_topic_score_codex":0.000014476506,"about_ca_topic_score_gemma":0.00009045441,"teacher_disagreement_score":0.765214,"about_ca_system_score_codex":0.00012078931,"about_ca_system_score_gemma":0.00005706053,"threshold_uncertainty_score":0.99992377},"labels":[],"label_agreement":null},{"id":"W2805115131","doi":"10.1177/1756284818777938","title":"Different clinical outcomes in Crohn’s disease patients with esophagogastroduodenal, jejunal, and proximal ileal disease involvement: is L4 truly a single phenotype?","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Gastroenterology; Internal medicine; Crohn's disease; Ileum; Concomitant; Jejunum; Disease; Retrospective cohort study","score_opus":0.01167040709834665,"score_gpt":0.2759898635096872,"score_spread":0.2643194564113405,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2805115131","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99775,0.0005245719,0.0005587501,0.00019318923,0.00020674292,0.00064295926,0.00009293617,0.00001665102,0.00001422135],"genre_scores_gemma":[0.9965585,0.00013931494,0.00025178073,0.0025946184,0.00017532811,0.0001189242,0.00008340233,0.000043528788,0.000034588036],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99747723,0.00031264083,0.0005498603,0.00079530623,0.00022083476,0.00064412033],"domain_scores_gemma":[0.9988367,0.00002508017,0.00019260074,0.0005060043,0.00008909061,0.00035050215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015692157,0.00037865955,0.00039009034,0.00011472333,0.00006883331,0.000024012412,0.00027642443,0.00008449675,0.000047485122],"category_scores_gemma":[0.000046529967,0.00030501105,0.00009736532,0.00005732052,0.00080790365,0.000036255282,0.00020164112,0.00018176429,0.0000061494743],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.018540097,0.0014037251,0.977712,0.000043446336,0.000073633804,0.00008909819,0.00008089865,0.000018061743,0.000055359567,0.000031112737,0.000013716806,0.0019388762],"study_design_scores_gemma":[0.0060388795,0.0015920738,0.99121666,0.00003899972,0.00006404688,9.062745e-7,0.000033580745,0.000100112746,0.000018959834,0.00036651143,0.00033374853,0.00019550124],"about_ca_topic_score_codex":0.0000026965397,"about_ca_topic_score_gemma":0.0004739758,"teacher_disagreement_score":0.013504706,"about_ca_system_score_codex":0.00004638758,"about_ca_system_score_gemma":0.00005865874,"threshold_uncertainty_score":0.9999402},"labels":[],"label_agreement":null},{"id":"W2809588344","doi":"10.1177/1756284818783614","title":"Vedolizumab and early postoperative complications in nonintestinal surgery: a case-matched analysis","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"UCB Pharma; Sun Pharma; Takeda Oncology; Gilead Sciences; University of Chicago; Pfizer; AstraZeneca; Eli Lilly and Company","keywords":"Medicine; Vedolizumab; Perioperative; Surgery; Ulcerative colitis; Inflammatory bowel disease; Internal medicine; Disease","score_opus":0.01144452840463385,"score_gpt":0.28262887396106817,"score_spread":0.27118434555643434,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2809588344","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99376297,0.0003732457,0.005303322,0.0002229683,0.000045927267,0.00016761597,0.000013504032,0.000009220457,0.00010121027],"genre_scores_gemma":[0.99832886,0.00007984317,0.0007181696,0.00072724436,0.000036267535,0.00006272401,0.000023000515,0.00001282188,0.000011038172],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987403,0.00023716527,0.00028289208,0.0003668926,0.00005256063,0.0003201692],"domain_scores_gemma":[0.9994649,0.00003924154,0.000089011526,0.00027219462,0.00007286058,0.00006175],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018321678,0.0001533702,0.00025214968,0.00021028002,0.000055965742,0.0000112819425,0.000108737404,0.000063045525,0.000017390217],"category_scores_gemma":[0.000030257746,0.0001544189,0.000060393366,0.00018195099,0.0004226428,0.000013369593,0.00006717397,0.00009460853,0.0000045103375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009591153,0.00007685615,0.9943776,0.000005157118,0.000088866065,0.0002615085,0.00024864342,0.00011450472,0.0020471355,0.00010689747,0.0000043137165,0.0017094007],"study_design_scores_gemma":[0.00079286646,0.00039645153,0.9966069,0.000010414827,0.000056561614,0.00046433994,0.00015700288,0.00060030416,0.00014993387,0.0002731414,0.0003782255,0.00011388975],"about_ca_topic_score_codex":0.00004156781,"about_ca_topic_score_gemma":0.0054707364,"teacher_disagreement_score":0.0054291687,"about_ca_system_score_codex":0.00002415531,"about_ca_system_score_gemma":0.00003087032,"threshold_uncertainty_score":0.62970203},"labels":[],"label_agreement":null},{"id":"W2898696583","doi":"10.1177/1756284818805597","title":"Insights into the evaluation and management of dyspepsia: recent developments and new guidelines","year":2018,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Helicobacter pylori-related gastroenterology studies","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Epigastric pain; Proton-pump inhibitor; Internal medicine; Gastroenterology; Pill; Endoscopy; Small intestinal bacterial overgrowth; Distress; Cisapride; Irritable bowel syndrome","score_opus":0.11539051556216302,"score_gpt":0.4147446486955352,"score_spread":0.29935413313337217,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2898696583","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004532749,0.9917006,0.0002662061,0.0011399031,0.00042553,0.0017709197,0.000001790818,0.000019892765,0.00014244716],"genre_scores_gemma":[0.00059619773,0.9939132,0.004104149,0.0009649991,0.00009753481,0.00021633906,0.000028169732,0.000041733543,0.000037674137],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99687916,0.00047638817,0.0012555809,0.00064729963,0.00031651123,0.0004250375],"domain_scores_gemma":[0.9985202,0.00009005878,0.00056982815,0.00044491267,0.00027501688,0.000099985875],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049867656,0.00050867314,0.0015926046,0.0003075122,0.00007619427,0.000008298495,0.00022200863,0.00021986492,0.000016818405],"category_scores_gemma":[0.000054122105,0.00032158315,0.00008186977,0.0002703736,0.00065908517,0.000099984536,0.0003661197,0.0003943125,0.0000061420574],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00030112,0.000053365056,0.0023185872,0.0020594336,0.0012058083,0.000015848398,0.0005928346,8.392299e-7,6.9346413e-7,0.000046717447,0.00008142018,0.9933233],"study_design_scores_gemma":[0.0022401607,0.0012635019,0.004014536,0.0071192607,0.002526976,0.00025537747,0.00022656293,0.000017110442,0.0000011554953,0.0008256268,0.9813657,0.00014402946],"about_ca_topic_score_codex":0.000008579793,"about_ca_topic_score_gemma":0.0001917955,"teacher_disagreement_score":0.9931793,"about_ca_system_score_codex":0.00016831383,"about_ca_system_score_gemma":0.0001000779,"threshold_uncertainty_score":0.99992365},"labels":[],"label_agreement":null},{"id":"W2946059666","doi":"10.1177/1756284819851510","title":"Efficacy and safety of a ready-to-drink bowel preparation for colonoscopy: a randomized, controlled, non-inferiority trial","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring Pharmaceuticals","keywords":"Medicine; Tolerability; Colonoscopy; Clinical endpoint; Adverse effect; Nausea; Randomized controlled trial; Internal medicine; Vomiting; Confidence interval; Gastroenterology; Colorectal cancer","score_opus":0.010494155378295773,"score_gpt":0.3229618172978645,"score_spread":0.3124676619195687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2946059666","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9560212,0.00059999595,0.034004543,0.00043348622,0.0004995327,0.008183149,0.0000070812616,0.000025102,0.00022594612],"genre_scores_gemma":[0.99667484,0.00028366825,0.0016459841,0.0005356184,0.00009810148,0.0006861688,0.000009718827,0.000013371571,0.00005253084],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.99854904,0.00019258956,0.00058900873,0.0003031399,0.00011459986,0.00025161525],"domain_scores_gemma":[0.9988319,0.00059187534,0.00024080281,0.00019094773,0.0000823898,0.00006205375],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00079322857,0.00015773537,0.0013388599,0.00015173444,0.00002724157,0.0000055671276,0.000057134108,0.0000866262,0.00001498284],"category_scores_gemma":[0.00014143156,0.00012566373,0.00013435209,0.000079558726,0.00012297125,0.00008031254,0.000025537833,0.00012953713,0.0000019323866],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9914656,0.00013229491,0.0038916497,0.00006386163,0.0001167028,5.909428e-7,0.00027018297,0.00027377068,0.0006628418,0.00007295463,0.0000026310265,0.0030468907],"study_design_scores_gemma":[0.9388197,0.051794335,0.0030142418,0.00008936691,0.0001877728,0.000019468898,0.00004426085,0.0045995684,0.00024601223,0.00025351808,0.0008617594,0.00006998093],"about_ca_topic_score_codex":0.00002042648,"about_ca_topic_score_gemma":0.00012835285,"teacher_disagreement_score":0.052645914,"about_ca_system_score_codex":0.00006251685,"about_ca_system_score_gemma":0.000035386132,"threshold_uncertainty_score":0.5124419},"labels":[],"label_agreement":null},{"id":"W2962999280","doi":"10.1177/1756284819863015","title":"Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?","year":2019,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":30,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Endoscopy; Histology; Gold standard (test); Inflammation; Crypt; Colorectal cancer; Pathology; Disease; Radiology; Internal medicine; Cancer","score_opus":0.006374526017557489,"score_gpt":0.27758627589576146,"score_spread":0.27121174987820396,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2962999280","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99245673,0.0008318574,0.005212273,0.00017557529,0.00014828237,0.001075323,0.000026368501,0.000017386172,0.000056188386],"genre_scores_gemma":[0.99472386,0.00049032876,0.004052754,0.0001911841,0.00004199036,0.00037589818,0.00008277833,0.000028202874,0.000012988571],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9984307,0.00018087185,0.0004904142,0.000415341,0.00008873933,0.0003938833],"domain_scores_gemma":[0.9992931,0.000032990858,0.0002428174,0.0003108359,0.000052142364,0.000068099944],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028697622,0.00020892966,0.00028575127,0.00016976842,0.000023486002,0.000005322837,0.00017383657,0.00010780476,0.000005790084],"category_scores_gemma":[0.000024320902,0.00022260929,0.00005401322,0.00003680581,0.0001768626,0.000024373314,0.00008423964,0.00011806392,2.6506473e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019129801,0.00006373335,0.9304145,0.0004272298,0.000020778878,0.000009130307,0.000059366288,0.0014658844,0.059490755,0.0014660249,8.776597e-7,0.0046687666],"study_design_scores_gemma":[0.005616089,0.0011742339,0.97661215,0.00014859307,0.00003308646,0.000009179012,0.00015245477,0.00496822,0.005729392,0.0040360936,0.0012382849,0.00028223195],"about_ca_topic_score_codex":0.0000029585833,"about_ca_topic_score_gemma":0.00028986324,"teacher_disagreement_score":0.053761363,"about_ca_system_score_codex":0.00006889543,"about_ca_system_score_gemma":0.000092614784,"threshold_uncertainty_score":0.9077744},"labels":[],"label_agreement":null},{"id":"W2972047604","doi":"10.1177/1756284819870977","title":"Insights into the role of cannabis in the management of inflammatory bowel disease","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Cannabis and Cannabinoid Research","field":"Medicine","cited_by":31,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Cannabidiol; Cannabis; Medicine; Inflammatory bowel disease; Endocannabinoid system; Disease; Effects of cannabis; Clinical trial; Cannabinoid; Intensive care medicine; Internal medicine; Psychiatry","score_opus":0.016359062873174013,"score_gpt":0.33174517637602485,"score_spread":0.31538611350285084,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2972047604","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006383871,0.9901217,0.000012778485,0.00078706216,0.00013511525,0.002104352,0.00000817158,0.000005855666,0.00044106253],"genre_scores_gemma":[0.023426687,0.97528017,0.000019215124,0.00027720595,0.000050702663,0.0006091661,0.000022863125,0.000037045145,0.0002769335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99713886,0.00062498887,0.0009284748,0.00039035725,0.0004719624,0.0004453849],"domain_scores_gemma":[0.9984097,0.000039381855,0.00041496992,0.0010024068,0.00006525195,0.00006828485],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00048596514,0.0003449391,0.0012618464,0.00037098408,0.000028047254,0.000005849265,0.0008196883,0.0001230258,0.000029617277],"category_scores_gemma":[0.000009647248,0.00018039173,0.00035399562,0.00034312866,0.000567539,0.00006456597,0.00020471294,0.000657462,0.000005875172],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009504183,0.00037340156,0.0059408043,0.026264109,0.00031401747,0.00007195326,0.0011800262,0.000036314992,0.0000026688147,0.0024708104,0.000059211503,0.96233624],"study_design_scores_gemma":[0.0009251708,0.00051614514,0.0074238433,0.0043902304,0.00053939107,0.000017982935,0.0009112586,0.000032054275,0.0000014631737,0.0013466722,0.9837964,0.00009938914],"about_ca_topic_score_codex":0.000036805657,"about_ca_topic_score_gemma":0.00018219001,"teacher_disagreement_score":0.9837372,"about_ca_system_score_codex":0.00014535783,"about_ca_system_score_gemma":0.00020322825,"threshold_uncertainty_score":0.73561615},"labels":[],"label_agreement":null},{"id":"W2974496516","doi":"10.1177/1756284819870911","title":"Impact of the gut microbiota on immune checkpoint inhibitor-associated toxicities","year":2019,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Gut microbiota and health","field":"Biochemistry, Genetics and Molecular Biology","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Sunnybrook Health Science Centre","funders":"Canadian Cancer Society Research Institute; Canadian Institutes of Health Research","keywords":"Medicine; Inflammatory bowel disease; Gut flora; Immune system; Diarrhea; Colitis; Immunology; Disease; Discontinuation; Gastroenterology; Internal medicine","score_opus":0.022655417149853432,"score_gpt":0.3423823525466908,"score_spread":0.3197269353968374,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2974496516","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.054562256,0.9436426,0.000014110838,0.000029923023,0.00063366006,0.00081676734,0.00018713213,0.0000074724576,0.000106081396],"genre_scores_gemma":[0.061519235,0.9376633,0.000018984576,0.00019033128,0.00010231282,0.00003353333,0.00018390336,0.00006271173,0.00022568203],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972913,0.00056373316,0.00089392083,0.0005237657,0.00009890122,0.00062833243],"domain_scores_gemma":[0.9981991,0.000043637356,0.0008491073,0.00081612397,0.000051172214,0.000040874205],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026792215,0.00051902153,0.0014824836,0.00013703128,0.0000476447,0.000008139953,0.0006807192,0.00048549456,0.000029669658],"category_scores_gemma":[0.000027208567,0.0003358676,0.0009410252,0.00014981833,0.0002958483,0.000005022026,0.00024812037,0.0005332778,0.000013617207],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0036536867,0.003587945,0.018388694,0.020354988,0.0043409006,0.000013814008,0.000468975,0.00049497467,0.2972948,0.00016201597,0.00063373614,0.6506055],"study_design_scores_gemma":[0.0050059916,0.013388261,0.028848998,0.015253693,0.00084159215,0.00026159987,0.0000762631,0.00000449228,0.0010666824,0.0001402052,0.9339532,0.0011589887],"about_ca_topic_score_codex":0.00001908023,"about_ca_topic_score_gemma":0.000101256315,"teacher_disagreement_score":0.9333195,"about_ca_system_score_codex":0.00020501537,"about_ca_system_score_gemma":0.0002650419,"threshold_uncertainty_score":0.99990934},"labels":[],"label_agreement":null},{"id":"W3001750915","doi":"10.1177/1756284819897531","title":"Mechanism of action and therapeutic benefit of rifaximin in patients with irritable bowel syndrome: a narrative review","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Infant Health and Development","field":"Health Professions","cited_by":54,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Salix Pharmaceuticals","keywords":"Rifaximin; Irritable bowel syndrome; Medicine; Small intestinal bacterial overgrowth; Gastroenterology; Internal medicine; Gut flora; Context (archaeology); Intestinal permeability; Diarrhea; Abdominal pain; Antibiotics; Immunology","score_opus":0.0418792466789998,"score_gpt":0.39903775116272167,"score_spread":0.3571585044837219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3001750915","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002266385,0.9930941,0.00021966264,0.0001670894,0.00027661197,0.0038114802,0.000061236635,0.000015522515,0.00008791062],"genre_scores_gemma":[0.0064589973,0.9909303,0.0005453635,0.0012993758,0.000014017537,0.0006188218,0.00006574527,0.000047457914,0.000019911853],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954751,0.0010988723,0.0019076376,0.0005266595,0.0002728862,0.0007188527],"domain_scores_gemma":[0.9974702,0.00032207443,0.0016621865,0.00030525602,0.00013347025,0.00010678498],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0006437802,0.00047547495,0.003034693,0.0003406914,0.00008794456,0.0000013049764,0.00026765943,0.0003089703,0.00008648398],"category_scores_gemma":[0.00002587572,0.00035197628,0.00009552343,0.00039533238,0.0001490879,0.00012591429,0.000113722366,0.0010311311,0.000005550675],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001993522,0.00039922152,0.026719064,0.18662402,0.00031097486,0.00001892337,0.003289848,0.0000033233712,3.193242e-7,0.0017507311,0.000009620598,0.7788804],"study_design_scores_gemma":[0.014832478,0.013668296,0.032980897,0.37926728,0.0015725847,0.00011242873,0.0021532858,0.000032880336,0.0000012104448,0.007914474,0.54615766,0.001306507],"about_ca_topic_score_codex":0.000031532032,"about_ca_topic_score_gemma":0.00033862315,"teacher_disagreement_score":0.77757394,"about_ca_system_score_codex":0.00025289005,"about_ca_system_score_gemma":0.0003734873,"threshold_uncertainty_score":0.99989325},"labels":[],"label_agreement":null},{"id":"W3004927985","doi":"10.1177/1756284820902878","title":"Efficacy, safety, and tolerability of a ready-to-drink bowel preparation: subanalysis by age from a phase III, assessor-blinded study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring","keywords":"Tolerability; Medicine; Colonoscopy; Adverse effect; Internal medicine; Post-hoc analysis; Clinical endpoint; Randomized controlled trial; Gastroenterology; Colorectal cancer; Cancer","score_opus":0.033024671102554616,"score_gpt":0.3610694429592313,"score_spread":0.3280447718566767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3004927985","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.97121507,0.00075661804,0.025580086,0.0014612115,0.000058844955,0.00079563,0.000031946067,0.000047731166,0.000052869324],"genre_scores_gemma":[0.99788076,0.00009819963,0.00055868237,0.0012921967,0.000060004604,0.000047562833,0.000043023494,0.000013046747,0.000006545092],"study_design_codex":"randomized_trial","study_design_gemma":"observational","domain_scores_codex":[0.9982008,0.00023722973,0.00061790255,0.00050988805,0.00020314453,0.00023104543],"domain_scores_gemma":[0.99921066,0.00012868734,0.00018587148,0.00027800383,0.000053115968,0.00014367086],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022498777,0.00017940698,0.00074623595,0.00009293385,0.000037421916,0.0000090420735,0.00010736443,0.00006250538,0.000057586247],"category_scores_gemma":[0.00005268492,0.00016589268,0.0000623861,0.00026768335,0.00011533117,0.00009727855,0.000065001586,0.00022196372,0.0000010407454],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.50607234,0.0028132787,0.40135798,0.00004594254,0.0004829518,0.000039536444,0.0073836762,0.000981665,0.007744588,0.0000038360704,0.00003111816,0.073043056],"study_design_scores_gemma":[0.12911688,0.2302633,0.5940392,0.0001462815,0.0018218786,0.00005565377,0.005259028,0.02396679,0.0059993966,0.00040583644,0.008284615,0.0006411726],"about_ca_topic_score_codex":0.000119987024,"about_ca_topic_score_gemma":0.000936859,"teacher_disagreement_score":0.37695548,"about_ca_system_score_codex":0.00006190556,"about_ca_system_score_gemma":0.00001767364,"threshold_uncertainty_score":0.6764907},"labels":[],"label_agreement":null},{"id":"W3015999147","doi":"10.1177/1756284820910050","title":"Efficacy, safety, and tolerability of a ready-to-drink bowel preparation in overweight and obese adults: subanalysis by body mass index from a phase III, assessor-blinded study","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"Ferring","keywords":"Tolerability; Medicine; Overweight; Body mass index; Internal medicine; Clinical endpoint; Adverse effect; Underweight; Post-hoc analysis; Gastroenterology; Randomized controlled trial","score_opus":0.015413100651675324,"score_gpt":0.33016381846527304,"score_spread":0.3147507178135977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3015999147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98417234,0.0010156056,0.012934038,0.0008218444,0.00003991751,0.0009363443,0.00003314417,0.00002835591,0.000018390067],"genre_scores_gemma":[0.99872255,0.000270834,0.00028442973,0.0005794919,0.00003497008,0.00005842361,0.00003396971,0.000012884683,0.0000024681733],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99805814,0.0002716702,0.0006595465,0.0005686707,0.00019765788,0.00024430722],"domain_scores_gemma":[0.9992509,0.00014232328,0.00019666871,0.00022627707,0.000054755612,0.00012908841],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002590684,0.00019518271,0.00073338096,0.00015255448,0.000027403603,0.0000094723855,0.00008273697,0.00008385244,0.000025895113],"category_scores_gemma":[0.00006690228,0.00018161925,0.00003870179,0.00028015402,0.00010687046,0.00014876171,0.00006061024,0.00026720072,3.5714658e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.25031558,0.000986946,0.7282949,0.000032991684,0.00010454142,0.000009630565,0.0024537938,0.00026222444,0.0020926155,0.0000010451985,0.0000024766234,0.015443232],"study_design_scores_gemma":[0.052038245,0.047475796,0.85461575,0.00011796223,0.00025991618,0.000011484593,0.0022709644,0.041679297,0.0008696464,0.00015019634,0.00031701295,0.00019370802],"about_ca_topic_score_codex":0.0003143952,"about_ca_topic_score_gemma":0.0021569186,"teacher_disagreement_score":0.19827732,"about_ca_system_score_codex":0.00008552051,"about_ca_system_score_gemma":0.000018605178,"threshold_uncertainty_score":0.7406218},"labels":[],"label_agreement":null},{"id":"W3024086321","doi":"10.1177/1756284820922746","title":"Optical evaluation: the crux for effective management of colorectal neoplasia","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Endoscopic submucosal dissection; Endoscopic mucosal resection; Colorectal cancer; Resection; Dissection (medical); Colorectal Polyp; Colonoscopy; Surgery; General surgery; Radiology; Cancer; Internal medicine","score_opus":0.0360485543058619,"score_gpt":0.3842003311822021,"score_spread":0.3481517768763402,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3024086321","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0002822206,0.9840792,0.007857256,0.00018242578,0.0004922358,0.006534377,0.000017086892,0.000029143499,0.00052604725],"genre_scores_gemma":[0.007871551,0.9854676,0.0013856223,0.00013975998,0.0001531123,0.0048860987,0.000043151642,0.0000388072,0.000014283493],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99813515,0.0003195914,0.0005446542,0.00042938848,0.0002602747,0.0003109707],"domain_scores_gemma":[0.9988971,0.00041865118,0.0003030045,0.00024340586,0.00008467268,0.00005321125],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005049782,0.0002996124,0.0013739289,0.000117051095,0.000041308766,0.000005474143,0.0001911311,0.00014786553,0.000026438738],"category_scores_gemma":[0.000032834774,0.00019940393,0.00037547012,0.00025496687,0.00021539346,0.000040371106,0.000071536044,0.00038979438,0.000004179042],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00899258,0.00006484567,0.000058061138,0.004405237,0.00044410484,0.000009665384,0.00005202463,0.000026136338,4.319931e-7,0.00016934815,0.000005619497,0.98577195],"study_design_scores_gemma":[0.0035893428,0.017702045,0.0005321579,0.0042094775,0.004323299,0.00038876195,0.000113869115,0.0009325802,0.0000087701865,0.00048857555,0.96755767,0.00015345268],"about_ca_topic_score_codex":0.0000011724719,"about_ca_topic_score_gemma":0.000023543087,"teacher_disagreement_score":0.9856185,"about_ca_system_score_codex":0.0002584236,"about_ca_system_score_gemma":0.00007765826,"threshold_uncertainty_score":0.81314564},"labels":[],"label_agreement":null},{"id":"W3031965734","doi":"10.1177/1756284820927550","title":"Complementary and alternative medications in the management of inflammatory bowel disease","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Complementary and Alternative Medicine Studies","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Intensive care medicine; Disease; Narrative review; Crohn's disease; Alternative medicine; Ulcerative colitis; Drug; Internal medicine; Pharmacology; Pathology","score_opus":0.046080959107641685,"score_gpt":0.3873131602752891,"score_spread":0.3412322011676474,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3031965734","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014011275,0.99521387,0.00026097154,0.001260868,0.00014172775,0.001481861,0.00006333005,0.000008116786,0.00016811962],"genre_scores_gemma":[0.015324335,0.98316664,0.00023304977,0.0007224815,0.000112048794,0.00031186626,0.000107573804,0.0000166828,0.000005353954],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.998022,0.0003453301,0.00074609445,0.00036342806,0.00025001488,0.00027310415],"domain_scores_gemma":[0.9991135,0.00022046093,0.00030370915,0.00027327586,0.000017729946,0.00007134656],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026805545,0.0002992752,0.0010586898,0.00021003862,0.000033413926,0.0000023925982,0.00031555243,0.000013928361,0.00005534753],"category_scores_gemma":[0.0000059793765,0.00019339636,0.00011327318,0.00015081123,0.00045677598,0.00005544098,0.00020440412,0.00036957941,0.0000018508096],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005445184,0.0002806093,0.04359462,0.014324265,0.0011193068,0.000668498,0.0010394173,0.0000024010005,1.2120059e-7,0.0024525546,0.0000138078085,0.9359599],"study_design_scores_gemma":[0.0031963834,0.0012525254,0.038350955,0.010972058,0.002068923,0.000095759555,0.0022789438,0.000041066956,7.3104175e-8,0.001638426,0.9399528,0.00015207857],"about_ca_topic_score_codex":0.0000060611983,"about_ca_topic_score_gemma":0.00004749671,"teacher_disagreement_score":0.939939,"about_ca_system_score_codex":0.000069604015,"about_ca_system_score_gemma":0.000028851928,"threshold_uncertainty_score":0.78864753},"labels":[],"label_agreement":null},{"id":"W3094596778","doi":"10.1177/1756284820961299","title":"Berberine for diarrhea in children and adults: a systematic review and meta-analysis","year":2020,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Berberine and alkaloids research","field":"Medicine","cited_by":49,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"National Key Research and Development Program of China Stem Cell and Translational Research","keywords":"Medicine; Diarrhea; Berberine; Internal medicine; Randomized controlled trial; Clinical trial; Antibiotic-associated diarrhea; Pediatrics; Antibiotics; Pharmacology","score_opus":0.042374588407488305,"score_gpt":0.3862551853325447,"score_spread":0.3438805969250564,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3094596778","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000027386472,0.9923403,0.00023946541,0.0009657974,0.000009504367,0.0062716543,0.00012153613,0.000016095319,0.00000824602],"genre_scores_gemma":[0.00013157853,0.99503183,0.00046067726,0.0016570501,0.000027545768,0.0024310616,0.00014446722,0.000048485515,0.00006728599],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.996822,0.0005369844,0.0012227403,0.0007504593,0.00016603363,0.000501807],"domain_scores_gemma":[0.998696,0.0003006084,0.0003630902,0.00044638276,0.000044017892,0.00014986203],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056051,0.0005169501,0.010086211,0.00048015904,0.000021426156,0.000011763786,0.0002083626,0.00014242892,0.000056000954],"category_scores_gemma":[0.000107434804,0.00033721578,0.00087643537,0.0006012853,0.00016584301,0.00008335282,0.0001393252,0.0005219638,0.0000029569844],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001595339,0.00009978334,0.00069251156,0.8960468,0.057518627,0.000027639364,0.000031194006,4.2389246e-7,3.1937805e-8,0.000024433944,0.0000045064066,0.045394514],"study_design_scores_gemma":[0.0019071093,0.0014399319,0.0001471479,0.036023922,0.92131966,0.0007743439,0.000013825912,0.000033340104,6.120088e-8,0.0000730223,0.0379718,0.00029580857],"about_ca_topic_score_codex":0.000015168461,"about_ca_topic_score_gemma":0.00016098222,"teacher_disagreement_score":0.86380106,"about_ca_system_score_codex":0.000055724096,"about_ca_system_score_gemma":0.000038881648,"threshold_uncertainty_score":0.999908},"labels":[],"label_agreement":null},{"id":"W3106878288","doi":"10.1177/1756284820968732","title":"Classifying Crohn’s disease into colon-involving versus non-colon-involving groups is a better predictor of clinical outcomes than the Montreal classification","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Internal medicine; Hazard ratio; Gastroenterology; Odds ratio; Interquartile range; Crohn's disease; Disease; Azathioprine; Colectomy; Retrospective cohort study; Confidence interval; Inflammatory bowel disease; Ulcerative colitis","score_opus":0.031577677813218984,"score_gpt":0.320503417605627,"score_spread":0.28892573979240804,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3106878288","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99265754,0.0011090823,0.0025089558,0.0024684763,0.0005829453,0.00055501086,0.00004145441,0.000025858151,0.000050647766],"genre_scores_gemma":[0.9931366,0.00073967525,0.00041258117,0.005082574,0.00037492733,0.00014334942,0.000057506153,0.000042006275,0.0000108211525],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9972107,0.0004971192,0.0008748921,0.00067139795,0.0002422508,0.0005036781],"domain_scores_gemma":[0.9984344,0.00016828634,0.00047097015,0.0006012532,0.00009354064,0.00023154821],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004029675,0.00032062887,0.00046229054,0.00005548129,0.00011742343,0.000020977444,0.0006358377,0.00018368369,0.000023505527],"category_scores_gemma":[0.0002218113,0.0002594659,0.00028990206,0.00009158154,0.0005887623,0.0000395805,0.00025970628,0.00033245728,0.000007757239],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011473359,0.00015388771,0.98200107,0.000085910346,0.000186889,0.00005361271,0.00062241545,0.00012754863,0.0026788476,0.000080956015,0.00008394672,0.0024515581],"study_design_scores_gemma":[0.003794479,0.00060936494,0.9893272,0.000030922463,0.000113952614,0.000001217111,0.00043604118,0.004406284,0.00009821596,0.00032337953,0.00069976563,0.00015919695],"about_ca_topic_score_codex":0.000016584616,"about_ca_topic_score_gemma":0.0006281181,"teacher_disagreement_score":0.00767888,"about_ca_system_score_codex":0.000044019598,"about_ca_system_score_gemma":0.00011280392,"threshold_uncertainty_score":0.99998575},"labels":[],"label_agreement":null},{"id":"W3107857591","doi":"10.1177/1756284820959252","title":"Genetic risk factors predict disease progression in Crohn’s disease patients of the Swiss inflammatory bowel disease cohort","year":2020,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung","keywords":"Medicine; Inflammatory bowel disease; Disease; Crohn's disease; Cohort; Ulcerative colitis; Internal medicine; Immunology; Gastroenterology","score_opus":0.004782532001545085,"score_gpt":0.23344268776446134,"score_spread":0.22866015576291626,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3107857591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9961684,0.0015320274,0.00029196142,0.00016141299,0.00025224226,0.0012510666,0.00031215168,0.00002070846,0.0000100340985],"genre_scores_gemma":[0.998237,0.0005950329,0.00004596964,0.00067451876,0.00009788597,0.00019722467,0.00009531741,0.000049955066,0.0000070638685],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99713314,0.0006310669,0.0006493493,0.0006823841,0.00034472762,0.00055933103],"domain_scores_gemma":[0.99827474,0.000021944854,0.00038506507,0.0006857839,0.00007479656,0.0005576945],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00013480733,0.00037230743,0.00027784414,0.000077477554,0.00007320489,0.000010622144,0.00062193687,0.00008797406,0.000022545697],"category_scores_gemma":[0.00022689522,0.00029346484,0.00019846381,0.00010914324,0.000477731,0.000029145556,0.00033221216,0.0002534984,0.0000030663466],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008825146,0.00035697213,0.9822934,0.00015916492,0.000042411895,0.00010373658,0.000093095616,0.0072576744,0.0001403439,0.000009602333,0.000018435176,0.00069997576],"study_design_scores_gemma":[0.0021268665,0.0001770853,0.9955016,0.00007390728,0.00010066328,2.5391574e-7,0.000026417165,0.0012424333,0.000045185483,0.00027260275,0.000249949,0.00018303566],"about_ca_topic_score_codex":0.0000036307847,"about_ca_topic_score_gemma":0.0000668566,"teacher_disagreement_score":0.013208159,"about_ca_system_score_codex":0.000050433606,"about_ca_system_score_gemma":0.00016685782,"threshold_uncertainty_score":0.9999517},"labels":[],"label_agreement":null},{"id":"W3156991610","doi":"10.1177/17562848211006672","title":"Relevance of monitoring transmural disease activity in patients with Crohn’s disease: current status and future perspectives","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":63,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Calprotectin; Crohn's disease; Ulcerative colitis; Disease; Inflammatory bowel disease; Inflammation; Magnetic resonance imaging; Internal medicine; Gastroenterology; Radiology","score_opus":0.009323395437941326,"score_gpt":0.2953765019398923,"score_spread":0.286053106501951,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3156991610","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28513417,0.71398336,0.000057074652,0.000008540383,0.00018588381,0.00048953935,0.00013488083,0.0000047939943,0.0000017534102],"genre_scores_gemma":[0.1408671,0.8586123,0.000056755613,0.000007796183,0.00015878584,0.00014142366,0.0001096742,0.000043093645,0.000003055529],"study_design_codex":"design_other","study_design_gemma":"observational","domain_scores_codex":[0.9977364,0.00047795998,0.00038647346,0.0007173625,0.00017647326,0.00050530664],"domain_scores_gemma":[0.99897075,0.000024859948,0.00028430703,0.0004455701,0.00007788759,0.00019664883],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00008214689,0.00044894018,0.00083856395,0.0001295038,0.000029541885,0.000009656605,0.0001990655,0.00010928753,0.000005926745],"category_scores_gemma":[0.000019030154,0.0003829617,0.00016344871,0.00010515533,0.00029309612,0.000026708422,0.000091587455,0.00033952078,2.552116e-7],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.005204599,0.000505924,0.42032534,0.004383753,0.000100203004,0.00008450434,0.00008715721,0.000036453148,0.0000013465776,0.000026215328,4.3197156e-7,0.5692441],"study_design_scores_gemma":[0.0021547198,0.00029984768,0.91812164,0.0028344602,0.00028649677,0.000001492554,0.00008506752,0.000002373442,8.396514e-7,0.000025199872,0.07586634,0.00032154456],"about_ca_topic_score_codex":9.4135424e-7,"about_ca_topic_score_gemma":0.00003241948,"teacher_disagreement_score":0.5689225,"about_ca_system_score_codex":0.00009525942,"about_ca_system_score_gemma":0.00021006429,"threshold_uncertainty_score":0.99986225},"labels":[],"label_agreement":null},{"id":"W3173320048","doi":"10.1177/17562848211004839","title":"Systematic review and meta-analysis: the impact of co-occurring immune-mediated inflammatory diseases on the disease localization and behavior of Crohn’s disease","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Novo Nordisk Fonden","keywords":"Medicine; Relative risk; Internal medicine; Gastroenterology; Subgroup analysis; Meta-analysis; Confidence interval; Disease; Crohn's disease; Inflammatory bowel disease","score_opus":0.012729716671526215,"score_gpt":0.2971758824145549,"score_spread":0.28444616574302867,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3173320048","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.82895684,0.16929837,0.00034326717,0.000126407,0.00001476921,0.0009314328,0.00032011786,0.0000055653663,0.0000032476648],"genre_scores_gemma":[0.9927713,0.0058331983,0.0000043650166,0.00092824904,0.000007893403,0.00033967066,0.000094263974,0.000015048353,0.000006007215],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9978604,0.00090187957,0.00058666157,0.00029541054,0.000149653,0.00020601887],"domain_scores_gemma":[0.99860036,0.00010780029,0.00040000153,0.0006666685,0.0001087441,0.00011643438],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003073165,0.00022410511,0.0007337004,0.00006427889,0.000057235608,0.000010307815,0.00020318538,0.000034652996,0.00004464631],"category_scores_gemma":[0.0002283657,0.00012552389,0.00044570875,0.000124057,0.00041189807,0.000015184528,0.00009480866,0.000080591046,4.585516e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00291684,0.0007906718,0.9194273,0.033260725,0.036336858,0.0002609154,0.00014537605,0.0053113387,0.0011439538,0.00035911793,0.000014582525,0.00003237384],"study_design_scores_gemma":[0.0005079222,0.00012962332,0.8676783,0.00037944622,0.13052832,0.0000061520077,0.0000879368,0.00035677242,0.00007767316,0.00011512672,0.0000048231236,0.00012792984],"about_ca_topic_score_codex":0.0000026076689,"about_ca_topic_score_gemma":0.00002048692,"teacher_disagreement_score":0.16381447,"about_ca_system_score_codex":0.000012884161,"about_ca_system_score_gemma":0.000069627866,"threshold_uncertainty_score":0.5118716},"labels":[],"label_agreement":null},{"id":"W3186595652","doi":"10.1177/17562848211031388","title":"Early cholangioscopy-assisted electrohydraulic lithotripsy in difficult biliary stones is cost-effective","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gallbladder and Bile Duct Disorders","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Université de Montréal; McGill University Health Centre","funders":"","keywords":"Medicine; Cost effectiveness; Lithotripsy; Surgery; Risk analysis (engineering)","score_opus":0.012150891076080842,"score_gpt":0.3034157697178832,"score_spread":0.29126487864180234,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3186595652","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98795563,0.006876798,0.0007328666,0.0024330802,0.00024445192,0.0012405444,0.000008499012,0.000057736423,0.00045039176],"genre_scores_gemma":[0.99211824,0.0016273323,0.00037221867,0.0052086394,0.0000607903,0.00041643978,0.000043016542,0.000034229364,0.00011908061],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9976957,0.0003380099,0.0004217582,0.00059380336,0.00020379625,0.00074694306],"domain_scores_gemma":[0.99920404,0.00011331174,0.00009626234,0.00037496292,0.00011028229,0.00010111215],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00016761647,0.00029251227,0.00063118286,0.0002797676,0.00003641132,0.000013539194,0.00014999857,0.00014629924,0.00014962889],"category_scores_gemma":[0.00004536404,0.00025742748,0.00012317472,0.0006334873,0.00018649848,0.00018245919,0.00005180651,0.0005335732,0.000020913323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0030913195,0.0012970332,0.8904558,0.00008679506,0.0001432518,0.00042180478,0.0012368772,0.000033887685,0.016785484,0.00003731755,0.000032698335,0.08637775],"study_design_scores_gemma":[0.006229879,0.0014774601,0.98453075,0.000105857456,0.000074816846,0.00046031654,0.00050545856,0.00010934866,0.0025338233,0.00052363507,0.0032924945,0.00015617379],"about_ca_topic_score_codex":0.000039397502,"about_ca_topic_score_gemma":0.0006004016,"teacher_disagreement_score":0.09407496,"about_ca_system_score_codex":0.00015642714,"about_ca_system_score_gemma":0.00006797533,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W3197157325","doi":"10.1177/17562848211036456","title":"Characteristics of patients with moderate-to-severe ulcerative colitis treated with vedolizumab: results from a Polish multicenter, prospective, observational real-life study (the POLONEZ study)","year":2021,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Takeda Pharmaceutical Company","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Internal medicine; Infliximab; Population; Concomitant; Inflammatory bowel disease; Observational study; Clinical trial; Disease","score_opus":0.012821596446894292,"score_gpt":0.26167320620898954,"score_spread":0.24885160976209525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3197157325","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99719685,0.00002113286,0.00026742968,0.00007175697,0.000064300795,0.0015918091,0.0007344373,0.000012393873,0.000039857845],"genre_scores_gemma":[0.9983208,0.000033723732,0.00021712542,0.0004959733,0.00006353869,0.00025329372,0.0005481881,0.000036283076,0.000031046216],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99760807,0.0006095894,0.00051176746,0.00063531485,0.0002639006,0.00037137972],"domain_scores_gemma":[0.99848205,0.000051536863,0.0003004197,0.0005462971,0.00051764573,0.00010202483],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012321069,0.0002925179,0.0003922589,0.000051729196,0.00009348896,0.000021305555,0.0002484444,0.000060313854,0.000014366318],"category_scores_gemma":[0.000072152696,0.00021612422,0.000037898724,0.00014444668,0.00019071836,0.000026094282,0.00012201775,0.00014950043,0.0000015144655],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.090604275,0.0022559182,0.90449846,0.0000067791616,0.00038337475,0.00007719253,0.00123011,0.0006373424,0.00011560619,0.000012830334,0.0000036079455,0.00017450472],"study_design_scores_gemma":[0.015317531,0.003786975,0.9790037,0.000022770413,0.00010216429,0.0000021987707,0.0013537945,0.000067774934,0.00014308706,0.000018044608,0.00002985701,0.00015205979],"about_ca_topic_score_codex":0.00008546499,"about_ca_topic_score_gemma":0.0055850837,"teacher_disagreement_score":0.075286746,"about_ca_system_score_codex":0.00006254438,"about_ca_system_score_gemma":0.00013891116,"threshold_uncertainty_score":0.88132894},"labels":[],"label_agreement":null},{"id":"W3207078983","doi":"10.1177/17562848211048127","title":"Defining the black box: a narrative review of factors associated with adverse outcomes from severe <i>Clostridioides difficile</i> infection","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"National Center for Advancing Translational Sciences; Division of Intramural Research, National Institute of Allergy and Infectious Diseases; National Institute of Allergy and Infectious Diseases; Canadian Institutes of Health Research; Michigan Institute for Clinical and Health Research; Agency for Healthcare Research and Quality","keywords":"Medicine; Clostridioides; Intensive care medicine; Disease; Adverse effect; Epidemiology; Metronidazole; Narrative review; Bioinformatics; Internal medicine; Antibiotics","score_opus":0.03973843512947874,"score_gpt":0.3547897648388154,"score_spread":0.3150513297093367,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3207078983","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.024230197,0.9730867,0.00004429414,0.00024598898,0.0001992606,0.0016582538,0.00029109424,0.000047759706,0.00019642504],"genre_scores_gemma":[0.012381655,0.9855437,0.00003103643,0.00054486765,0.00006320874,0.00018268432,0.0010970874,0.00009283394,0.00006290975],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9949142,0.0013297879,0.0014543599,0.00080819736,0.000701115,0.0007923406],"domain_scores_gemma":[0.9960925,0.0014529177,0.0011607661,0.0008603222,0.00029996276,0.00013351867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005142507,0.00085563987,0.00442047,0.0002677686,0.00010658663,0.000013357781,0.0003792671,0.00036307596,0.00030293345],"category_scores_gemma":[0.0006097251,0.0004961948,0.00086901715,0.0008807687,0.00067295105,0.00012717907,0.0001925841,0.0015525536,0.000009487307],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002187355,0.0040961504,0.15672135,0.10457689,0.014392268,0.00054460764,0.002946037,0.00016076835,0.000022942131,0.00025347766,0.0006344782,0.71346366],"study_design_scores_gemma":[0.009104973,0.0056921346,0.0061959033,0.5138077,0.013127573,0.0003087744,0.0028645908,0.000022614226,0.00016827807,0.00005974348,0.44718027,0.0014674088],"about_ca_topic_score_codex":0.00007719154,"about_ca_topic_score_gemma":0.00034279315,"teacher_disagreement_score":0.71199626,"about_ca_system_score_codex":0.00055701396,"about_ca_system_score_gemma":0.00054120854,"threshold_uncertainty_score":0.99974895},"labels":[],"label_agreement":null},{"id":"W4205369309","doi":"10.1177/17562848211059954","title":"Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues","year":2021,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":69,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Tumor necrosis factor alpha; Necrosis; Disease; Crohn's disease; Pathology; Internal medicine","score_opus":0.01287823099216795,"score_gpt":0.2917702193540052,"score_spread":0.27889198836183726,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4205369309","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.015742876,0.9822468,0.000054390566,0.00007650911,0.0007113732,0.00096925773,0.000119688935,0.000023108116,0.00005600156],"genre_scores_gemma":[0.010654572,0.98724794,0.00002709583,0.00052516017,0.00040079022,0.0006120057,0.00024776012,0.000115329305,0.00016932792],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.995307,0.0017998992,0.00090704457,0.00091485644,0.00023252514,0.00083864864],"domain_scores_gemma":[0.99824435,0.000098802986,0.0005009272,0.000920226,0.000064871805,0.00017080607],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044490947,0.0007243024,0.0010800457,0.00021700311,0.000088248904,0.000042396237,0.00082951144,0.00036109134,0.00004540726],"category_scores_gemma":[0.00010904565,0.0005761574,0.0005472907,0.000128289,0.00050533755,0.000023064698,0.00036922612,0.00080583006,0.000017653296],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0015691505,0.0005560874,0.105691224,0.0077438443,0.00057761394,0.0015527882,0.0002831054,0.00026966303,0.00018131314,0.00022902903,0.00058763556,0.8807585],"study_design_scores_gemma":[0.0008692522,0.0001161901,0.017095087,0.002103272,0.00017755684,0.000029861354,0.00006978523,0.0000049435,0.0000056777153,0.00006760087,0.97904634,0.00041443759],"about_ca_topic_score_codex":0.000002262311,"about_ca_topic_score_gemma":0.00040132285,"teacher_disagreement_score":0.9784587,"about_ca_system_score_codex":0.00015322758,"about_ca_system_score_gemma":0.00039095673,"threshold_uncertainty_score":0.999669},"labels":[],"label_agreement":null},{"id":"W4225899336","doi":"10.1177/17562848221092594","title":"Advanced technology for assessment of endoscopic and histological activity in ulcerative colitis: a systematic review and meta-analysis","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"Birmingham Biomedical Research Centre; National Institute for Health and Care Research","keywords":"Chromoendoscopy; Medicine; Endoscope; Endoscopy; Ulcerative colitis; Confidence interval; Internal medicine; Meta-analysis; Histology; Gastroenterology; Radiology; Colonoscopy; Colorectal cancer; Cancer; Disease","score_opus":0.0841974630530313,"score_gpt":0.4115164458532533,"score_spread":0.327318982800222,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4225899336","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00019363048,0.9925232,0.0027073373,0.0001721995,0.000035027846,0.0042611826,0.000061803396,0.00002153506,0.000024068575],"genre_scores_gemma":[0.015295368,0.9762069,0.0013002572,0.0001938641,0.0000040059103,0.0069423444,0.00002037669,0.000018280105,0.000018602525],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971874,0.00087921787,0.0009000045,0.0005964368,0.00013600702,0.0003009326],"domain_scores_gemma":[0.99822915,0.0005707654,0.0007910902,0.0003276485,0.000038680148,0.00004266783],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00066434464,0.00035516042,0.007906011,0.0007689111,0.000041218485,0.000003285535,0.00012338822,0.00016217792,0.00006021077],"category_scores_gemma":[0.000107275955,0.00025966176,0.00053009175,0.0006776442,0.00022997902,0.000060858147,0.00010042852,0.00052747177,5.7988668e-8],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0019531056,0.00028976344,0.00046629197,0.8632133,0.03496473,0.000027653625,0.00004779203,0.000012760598,6.2984253e-7,0.00026403577,3.4631842e-7,0.09875959],"study_design_scores_gemma":[0.0028542778,0.018340565,0.00054456835,0.018200615,0.9398354,0.00047423347,0.00013966765,0.00017741216,0.0000010165056,0.00045199748,0.018637186,0.00034305168],"about_ca_topic_score_codex":0.000008177322,"about_ca_topic_score_gemma":0.00059603096,"teacher_disagreement_score":0.9048707,"about_ca_system_score_codex":0.0003038907,"about_ca_system_score_gemma":0.00006407261,"threshold_uncertainty_score":0.9999856},"labels":[],"label_agreement":null},{"id":"W4285238373","doi":"10.1177/17562848221102679","title":"Management of hepatorenal syndrome in liver cirrhosis: a recent update","year":2022,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":53,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Toronto General Hospital; University of Toronto; University Health Network","funders":"","keywords":"Terlipressin; Hepatorenal syndrome; Medicine; Cirrhosis; Acute kidney injury; Liver transplantation; Ascites; Internal medicine; Intensive care medicine; Cardiorenal syndrome; Spontaneous bacterial peritonitis; Gastroenterology; Renal replacement therapy; Transplantation; Renal function","score_opus":0.0369236797759472,"score_gpt":0.332425439785549,"score_spread":0.2955017600096018,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285238373","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0014109089,0.9970278,0.000129949,0.00003390822,0.00020256914,0.0009456628,0.00005259442,0.000016688084,0.00017993072],"genre_scores_gemma":[0.0062534893,0.99260986,0.00019773959,0.00020007289,0.000013891629,0.00038980442,0.00028916873,0.000034039535,0.000011951951],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99797755,0.0003165559,0.00070870906,0.00040744856,0.00022505576,0.00036464687],"domain_scores_gemma":[0.9993137,0.00004725294,0.0002709137,0.0002988159,0.000012391787,0.000056902958],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002016679,0.00029157934,0.0012995189,0.00043255743,0.000015502166,0.0000022926602,0.00021179215,0.00008583766,0.00058824493],"category_scores_gemma":[5.893993e-7,0.00025745502,0.00019730385,0.00029814694,0.0000883538,0.000081943865,0.000065989705,0.00038178088,0.000012751751],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009460078,0.00044502754,0.004506091,0.02051868,0.0008171159,0.002672124,0.00008660979,0.00000891995,5.0314306e-8,0.00022678485,9.088009e-7,0.9697717],"study_design_scores_gemma":[0.0047186813,0.0017702881,0.008330965,0.017359113,0.0061892876,0.0014345645,0.00014170921,0.0000227491,4.922433e-7,0.00044501107,0.9592864,0.00030075473],"about_ca_topic_score_codex":0.00000675627,"about_ca_topic_score_gemma":0.000024143286,"teacher_disagreement_score":0.9694709,"about_ca_system_score_codex":0.00020283999,"about_ca_system_score_gemma":0.000048621016,"threshold_uncertainty_score":0.9999878},"labels":[],"label_agreement":null},{"id":"W4285281009","doi":"10.1177/17562848221102307","title":"The hospitalization burden of inflammatory bowel disease in China: a nationwide study from 2013 to 2018","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":15,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Poisson regression; Internal medicine; Ulcerative colitis; Confidence interval; Population; Disease burden; Disease; Gastroenterology; Pediatrics; Environmental health","score_opus":0.003936983264950322,"score_gpt":0.24246385636152176,"score_spread":0.23852687309657145,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4285281009","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9967675,0.0011884968,0.00057469873,0.00038988862,0.00028341552,0.0007300709,0.00003993005,0.0000081315275,0.000017835451],"genre_scores_gemma":[0.9988426,0.00020869498,0.000042559688,0.0002849054,0.00007092802,0.00044194725,0.000053531407,0.000021546562,0.00003328259],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99829686,0.00049979246,0.00038999759,0.00033359352,0.00019510533,0.00028467955],"domain_scores_gemma":[0.9992977,0.000022283435,0.0001525815,0.00042689423,0.000034065888,0.00006648998],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003270745,0.00014984615,0.00013862686,0.00010125905,0.00010204336,0.000007700561,0.00041878983,0.000027487431,0.00003442671],"category_scores_gemma":[0.000040459454,0.00013855213,0.00004697249,0.00009208229,0.00010412318,0.000013361859,0.00028628914,0.000116541814,0.00000267116],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0032767383,0.00023195609,0.9230868,0.000007355808,0.000034415432,0.000031468662,0.000845541,0.07060055,0.0012052351,0.00004028716,0.000034312456,0.0006053004],"study_design_scores_gemma":[0.00153472,0.0006338985,0.9925381,0.000006473759,0.000015292666,8.372413e-7,0.0008866781,0.00086397515,0.00003849226,0.00074825546,0.0026354422,0.000097851116],"about_ca_topic_score_codex":0.000070140784,"about_ca_topic_score_gemma":0.001287102,"teacher_disagreement_score":0.06973658,"about_ca_system_score_codex":0.00005363965,"about_ca_system_score_gemma":0.00005161248,"threshold_uncertainty_score":0.5649992},"labels":[],"label_agreement":null},{"id":"W4300688804","doi":"10.1177/17562848221127238","title":"A randomized controlled trial of a multicomponent online stress reduction intervention in inflammatory bowel disease","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Seven Oaks General Hospital; University of Calgary; University of Alberta","funders":"Canadian Institutes of Health Research; University of Alberta; American College of Gastroenterology","keywords":"Medicine; Inflammatory bowel disease; Randomized controlled trial; Intervention (counseling); Disease; Reduction (mathematics); Internal medicine; Psychiatry","score_opus":0.006967669901076994,"score_gpt":0.2717162647988911,"score_spread":0.2647485948978141,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4300688804","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99438393,0.0015837904,0.00059097516,0.00009603429,0.0006215826,0.002650137,0.000048440575,0.000010884779,0.000014200269],"genre_scores_gemma":[0.9973982,0.00034697112,0.000083348394,0.00010124672,0.00009641943,0.0017336793,0.00018410235,0.000022179143,0.00003386381],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9961534,0.0020139522,0.0009585248,0.00036552377,0.00020141744,0.00030716838],"domain_scores_gemma":[0.999054,0.000043121818,0.00047021222,0.00032483516,0.000041584648,0.00006624902],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009578191,0.00020580922,0.0006201227,0.00023464617,0.00003941529,0.0000047397666,0.00024885524,0.00005064496,0.00005089606],"category_scores_gemma":[0.00009692782,0.00019824955,0.0003441053,0.00005349641,0.00024781533,0.000014682535,0.00017046735,0.00020314984,5.016048e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.9569728,0.0016982888,0.019840645,0.000054949844,0.00010137367,0.00003943456,0.00009635767,0.01797233,0.0024690288,0.00009439634,0.0000011820956,0.00065921235],"study_design_scores_gemma":[0.98037994,0.0007300741,0.014456541,0.00003334148,0.000074927775,0.0000069406296,0.00031171777,0.0032554993,0.00007999164,0.00045664416,0.000095813586,0.00011856174],"about_ca_topic_score_codex":0.000007508598,"about_ca_topic_score_gemma":0.00013010923,"teacher_disagreement_score":0.023407144,"about_ca_system_score_codex":0.00007183405,"about_ca_system_score_gemma":0.000053082535,"threshold_uncertainty_score":0.8084382},"labels":[],"label_agreement":null},{"id":"W4302761323","doi":"10.1177/17562848221100106","title":"Impact of NAFLD on clinical outcomes in hepatocellular carcinoma treated with sorafenib: an international cohort study","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Sorafenib; Hepatocellular carcinoma; Internal medicine; Nonalcoholic fatty liver disease; Hazard ratio; Gastroenterology; Proportional hazards model; Cohort; Liver cancer; Liver disease; Confidence interval; Oncology; Fatty liver; Surgery; Disease","score_opus":0.03148064591378786,"score_gpt":0.3733056229236373,"score_spread":0.34182497700984943,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4302761323","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9985337,0.000112221845,0.000008594346,0.00009267801,0.000095288065,0.0010374147,0.000040334693,0.000015640131,0.000064123844],"genre_scores_gemma":[0.9991372,0.00008143507,0.00003370004,0.00029053626,0.000018365521,0.00033677512,0.0000703172,0.00002009923,0.00001153157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.998187,0.00041630777,0.0004642415,0.00039495126,0.00028210826,0.0002554088],"domain_scores_gemma":[0.99929005,0.00009320114,0.0001568667,0.00034244108,0.000036254045,0.00008119061],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026489916,0.00018884285,0.0006161267,0.00022875007,0.000025780313,0.000003160358,0.00017101591,0.000026269272,0.00020384345],"category_scores_gemma":[0.0000072502453,0.00013228571,0.00013064344,0.00011198207,0.00009967106,0.00009099358,0.000053589712,0.0002358714,0.0000015184796],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011549165,0.01544212,0.9697712,0.0000036607603,0.00064992206,0.0004928136,0.00018545805,0.00064890075,0.0000059337062,0.000013665347,7.34383e-7,0.0012363949],"study_design_scores_gemma":[0.010797366,0.036705792,0.9515612,0.000009644361,0.00014759682,0.00002376538,0.0002893414,0.00036427242,0.000006117491,0.000025024021,0.0000114057475,0.00005843526],"about_ca_topic_score_codex":0.00022024679,"about_ca_topic_score_gemma":0.00017643439,"teacher_disagreement_score":0.021263674,"about_ca_system_score_codex":0.00027303558,"about_ca_system_score_gemma":0.000047636957,"threshold_uncertainty_score":0.5394455},"labels":[],"label_agreement":null},{"id":"W4311280161","doi":"10.1177/17562848221136331","title":"Modified Mayo score <i>versus</i> Mayo score for evaluation of treatment efficacy in patients with ulcerative colitis: data from the tofacitinib OCTAVE program","year":2022,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":22,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Pfizer","keywords":"Tofacitinib; Ulcerative colitis; Medicine; Internal medicine; Clinical endpoint; Octave (electronics); Surgery; Randomized controlled trial; Disease; Rheumatoid arthritis","score_opus":0.045113884199184245,"score_gpt":0.3249951007128367,"score_spread":0.2798812165136525,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4311280161","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9946516,0.0002520407,0.00025770377,0.00007335949,0.00016291233,0.0028530695,0.0017071427,0.000008618359,0.00003352991],"genre_scores_gemma":[0.99377626,0.000041202384,0.00029411798,0.00029105644,0.00004687035,0.0013953527,0.0041258996,0.000024341056,0.0000048868565],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99798506,0.0005883301,0.0003241554,0.00051785074,0.0002432586,0.00034133182],"domain_scores_gemma":[0.9988797,0.00006863169,0.00021860229,0.0006822011,0.00011454072,0.000036343066],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00036621233,0.00020906323,0.00023288307,0.000043022857,0.00008302824,0.000008408113,0.00046415816,0.000047922254,0.000038123704],"category_scores_gemma":[0.00003483282,0.00016239705,0.000049789967,0.0000712277,0.00021258034,0.000019578929,0.00019381537,0.00010062711,4.4046806e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.119124904,0.0026035332,0.7977165,0.000026093425,0.00044745256,0.00000864881,0.0009641388,0.031631377,0.00018714392,0.00010891027,0.000037935293,0.04714339],"study_design_scores_gemma":[0.04980186,0.010208242,0.92971355,0.000032167747,0.00026159178,0.000001930833,0.00073366467,0.0053871493,0.00017279021,0.0002853397,0.0031777946,0.00022393992],"about_ca_topic_score_codex":0.000019620895,"about_ca_topic_score_gemma":0.0013979148,"teacher_disagreement_score":0.13199706,"about_ca_system_score_codex":0.00014856126,"about_ca_system_score_gemma":0.00014441709,"threshold_uncertainty_score":0.6622359},"labels":[],"label_agreement":null},{"id":"W4323967376","doi":"10.1177/17562848231158235","title":"Update on the role of upadacitinib in the treatment of adults with moderately to severely active ulcerative colitis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Ulcerative colitis; Adverse effect; Inflammatory bowel disease; Clinical trial; Placebo; Colitis; Drug; Janus kinase; Tofacitinib; Pharmacology; Internal medicine; Disease; Pathology; Cytokine","score_opus":0.019733564709320157,"score_gpt":0.3067597717585201,"score_spread":0.28702620704919996,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4323967376","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.39578623,0.5956023,0.00016617487,0.00019154571,0.00015398189,0.0062632705,0.0012022986,0.000016271582,0.00061799504],"genre_scores_gemma":[0.14589581,0.8524453,0.00004834624,0.00029713367,0.000051559517,0.0010647726,0.00013404185,0.000046581503,0.000016453241],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.997624,0.00090577966,0.00050527,0.0004367988,0.00015430724,0.0003738443],"domain_scores_gemma":[0.99887705,0.0001319831,0.0003616533,0.00053069287,0.000061015566,0.000037598078],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017757744,0.00038598594,0.0007992123,0.00012258535,0.000031783544,0.0000057617103,0.00044013376,0.00013430753,0.000011067104],"category_scores_gemma":[0.0000141116125,0.00020761011,0.00016867329,0.00016027963,0.00023905674,0.0000061646497,0.000044724387,0.00015908432,0.00000766931],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.09660807,0.0013134113,0.0005178237,0.0016096471,0.0011361,0.00017301581,0.0038893411,0.0014253831,0.000011343108,0.0015728038,0.000011420541,0.8917316],"study_design_scores_gemma":[0.009356502,0.03435094,0.03470353,0.009737799,0.0011125028,0.00015926224,0.007576093,0.00013679943,0.0010205009,0.0025812017,0.898023,0.0012418622],"about_ca_topic_score_codex":0.00001262043,"about_ca_topic_score_gemma":0.0015670359,"teacher_disagreement_score":0.89801157,"about_ca_system_score_codex":0.00006544291,"about_ca_system_score_gemma":0.00010875369,"threshold_uncertainty_score":0.8466095},"labels":[],"label_agreement":null},{"id":"W4362684655","doi":"10.1177/17562848231159452","title":"Is there an optimal sequence of biologic therapies for inflammatory bowel disease?","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":59,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"","keywords":"Medicine; Inflammatory bowel disease; Sequence (biology); Disease; Intensive care medicine; Bioinformatics; Internal medicine","score_opus":0.046848822251988095,"score_gpt":0.35779434098470464,"score_spread":0.31094551873271653,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4362684655","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02449959,0.97188973,0.0008884492,0.00002035539,0.00030550937,0.0014656426,0.00087278226,0.000046815843,0.000011131074],"genre_scores_gemma":[0.004689333,0.9925259,0.00044662986,0.00027000133,0.00023357525,0.00092649885,0.00070136366,0.00013598776,0.000070746435],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968249,0.00056088966,0.0008939974,0.00087845,0.00014446896,0.0006972698],"domain_scores_gemma":[0.9981312,0.00007412577,0.0006352523,0.00091373903,0.00009553762,0.00015012635],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0004221893,0.00062931824,0.001043759,0.00020429945,0.000060284496,0.000012966914,0.0009126046,0.00039501415,0.000032756445],"category_scores_gemma":[0.000042650354,0.00052802963,0.00054226175,0.00009260207,0.0005817895,0.000022626957,0.0001827075,0.00023427613,0.000011810368],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01360493,0.0009927276,0.08341181,0.055388752,0.0027854724,0.00039376644,0.0004782476,0.0013582058,0.000583645,0.001222729,0.00012862167,0.8396511],"study_design_scores_gemma":[0.002245903,0.0025111488,0.008933996,0.0032491912,0.0008301541,0.000037925165,0.00017373545,0.00017968605,0.000027759705,0.002004712,0.97871757,0.0010882055],"about_ca_topic_score_codex":0.0000010465317,"about_ca_topic_score_gemma":0.00006537809,"teacher_disagreement_score":0.97858894,"about_ca_system_score_codex":0.000047294674,"about_ca_system_score_gemma":0.00024228255,"threshold_uncertainty_score":0.9997171},"labels":[],"label_agreement":null},{"id":"W4367021126","doi":"10.1177/17562848231167953","title":"IBD barriers across the continents: a continent-specific analysis: Latin America","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sinai Health System; University of Calgary; Lunenfeld-Tanenbaum Research Institute","funders":"Pfizer","keywords":"Latin Americans; Medicine; Epidemiology; Health care; Healthcare system; Family medicine; Economic growth; Pathology; Political science","score_opus":0.02112578555837125,"score_gpt":0.33316709551729035,"score_spread":0.3120413099589191,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367021126","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002919854,0.9935083,0.0016246855,0.000092908966,0.00050487765,0.0009555942,0.0002901891,0.000052348118,0.000051267136],"genre_scores_gemma":[0.0020199642,0.99543077,0.000066916844,0.0007100926,0.00029146305,0.00060737337,0.00046772845,0.00011017798,0.0002955015],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9958008,0.000988348,0.0010331257,0.00093967956,0.00022244954,0.0010156072],"domain_scores_gemma":[0.99780893,0.00011317452,0.000707194,0.0011424726,0.00007203054,0.00015622286],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049708626,0.0006627169,0.0015491581,0.00021263656,0.00014498051,0.00004481637,0.0010701504,0.0003137346,0.000069085974],"category_scores_gemma":[0.000085743595,0.00048553167,0.0009039833,0.0005868584,0.0006996555,0.000010749138,0.00035575897,0.0004888833,0.00008170516],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0025242802,0.00025176862,0.031691853,0.0032356707,0.010248081,0.00053119555,0.0005639309,0.0010909745,0.00003400318,0.00013576781,0.0009241224,0.9487684],"study_design_scores_gemma":[0.0007429203,0.00016193352,0.0016853772,0.00032922009,0.0009798434,0.0000141944065,0.00024042591,0.000027790631,5.712491e-7,0.00004562239,0.995479,0.00029309516],"about_ca_topic_score_codex":0.0000050812787,"about_ca_topic_score_gemma":0.00037030014,"teacher_disagreement_score":0.9945549,"about_ca_system_score_codex":0.00005954745,"about_ca_system_score_gemma":0.00008744021,"threshold_uncertainty_score":0.9997596},"labels":[],"label_agreement":null},{"id":"W4367278801","doi":"10.1177/17562848231166227","title":"Vedolizumab subcutaneous formulation maintenance therapy for patients with IBD: a systematic review and meta-analysis","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Natural Science Foundation of China","keywords":"Medicine; Vedolizumab; Internal medicine; Cochrane Library; Ulcerative colitis; Placebo; Context (archaeology); Adverse effect; Randomized controlled trial; Meta-analysis; Inflammatory bowel disease; Crohn's disease; Cohort; Gastroenterology; Surgery; Disease; Pathology; Alternative medicine","score_opus":0.027555044110784205,"score_gpt":0.31802472313096497,"score_spread":0.2904696790201808,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4367278801","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00015271587,0.9924344,0.0015261964,0.000020070796,0.000037144462,0.005545049,0.00025930358,0.000020947322,0.0000041876506],"genre_scores_gemma":[0.0009210597,0.9940839,0.00019211366,0.0006560844,0.000021352218,0.0032363958,0.0006964872,0.000091373724,0.00010126071],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9971902,0.00051386096,0.0009260913,0.00072112866,0.00015558863,0.00049314497],"domain_scores_gemma":[0.9981899,0.000093641094,0.00081461173,0.00069438515,0.00013607011,0.000071374496],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00035827915,0.00057633553,0.0036569382,0.00020986915,0.000052961735,0.000016260932,0.00034103924,0.00018699445,0.00001096942],"category_scores_gemma":[0.000048146365,0.00037110675,0.00096383755,0.000223754,0.0001033839,0.00001329147,0.00006824017,0.00013803795,0.000003745205],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0022378922,0.00026417192,0.0004998663,0.8436821,0.14321807,0.000058231097,0.000028868755,0.00008126717,2.3692795e-7,0.00011300759,0.000018210389,0.009798071],"study_design_scores_gemma":[0.0029859343,0.0031885107,0.0002468927,0.012521808,0.9382258,0.00010064352,0.000013003586,0.00003236575,1.7899528e-7,0.00026977103,0.041483052,0.00093202846],"about_ca_topic_score_codex":8.0750897e-7,"about_ca_topic_score_gemma":0.00011430122,"teacher_disagreement_score":0.8311603,"about_ca_system_score_codex":0.00004624231,"about_ca_system_score_gemma":0.000048446058,"threshold_uncertainty_score":0.9998741},"labels":[],"label_agreement":null},{"id":"W4378901451","doi":"10.1177/17562848231171756","title":"A review of the role of intermittent fasting in the management of inflammatory bowel disease","year":2023,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Dietary Effects on Health","field":"Medicine","cited_by":11,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Ulcerative colitis; Disease; Observational study; Randomized controlled trial; Intermittent fasting; Crohn's disease; Weight loss; Colitis; Internal medicine; Clinical trial; Gastroenterology; Weight management; Microbiome; Animal studies; Bioinformatics; Obesity","score_opus":0.03118164510584033,"score_gpt":0.3663004977127716,"score_spread":0.3351188526069313,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4378901451","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00072307495,0.9956122,0.000015985977,0.00021709639,0.00017756327,0.0030843222,0.000022910051,0.000010006676,0.00013682437],"genre_scores_gemma":[0.0032049054,0.9955027,0.0000750643,0.00077221356,0.000026492902,0.0003537958,0.00001581028,0.00003849553,0.000010510196],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99627274,0.0010640434,0.0016326226,0.000317958,0.00033006846,0.00038257465],"domain_scores_gemma":[0.9974981,0.00031510225,0.001192474,0.0009016064,0.000044242275,0.000048496444],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001308048,0.0003196059,0.0018663474,0.00023254662,0.00001296916,0.0000011084593,0.0007219839,0.000068882895,0.00001126443],"category_scores_gemma":[0.00005094969,0.00017732583,0.00045578319,0.0004062519,0.0003207668,0.000043647837,0.00023753195,0.00049514783,0.0000026539199],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002019992,0.00018166687,0.007790888,0.38204715,0.00019290308,0.00002787128,0.00007455504,0.000007836737,3.0668647e-7,0.00014939782,0.0000030745741,0.60932237],"study_design_scores_gemma":[0.0012089458,0.0009769513,0.021221988,0.8149186,0.0024093513,0.000060517694,0.0003071738,0.000054335153,6.7038184e-7,0.0006132491,0.15808399,0.00014425156],"about_ca_topic_score_codex":0.0000060615625,"about_ca_topic_score_gemma":0.000023333829,"teacher_disagreement_score":0.6091781,"about_ca_system_score_codex":0.000090058864,"about_ca_system_score_gemma":0.00010367148,"threshold_uncertainty_score":0.7231138},"labels":[],"label_agreement":null},{"id":"W4380371766","doi":"10.1177/17562848231174277","title":"Safety of fecal microbiota, live-jslm (REBYOTA<sup>™</sup>) in individuals with recurrent <i>Clostridioides difficile</i> infection: data from five prospective clinical trials","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Foothills Medical Centre; University of British Columbia; University of Calgary; University of Victoria; Island Health","funders":"Ferring","keywords":"Medicine; Placebo; Adverse effect; Clinical trial; Nausea; Internal medicine; Regimen","score_opus":0.08476244952894932,"score_gpt":0.40750689638980137,"score_spread":0.322744446860852,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4380371766","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9923621,0.0025856944,0.00028316496,0.0010041753,0.00028969726,0.0019237712,0.0013447623,0.000091066395,0.000115604125],"genre_scores_gemma":[0.98342377,0.014135306,0.00042326606,0.00026864273,0.00042135883,0.0001269093,0.001092648,0.00005975484,0.000048354857],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99290305,0.0019765545,0.0022499498,0.0012878311,0.0005842358,0.0009983964],"domain_scores_gemma":[0.99533343,0.002475541,0.00055924745,0.0012380144,0.00018347907,0.00021030908],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0039033503,0.00049466325,0.0021647392,0.0005793017,0.000074979434,0.000022418975,0.00062980276,0.00032405258,0.0002481941],"category_scores_gemma":[0.0010667227,0.0003942161,0.0002378227,0.0010191743,0.0008075766,0.00026507507,0.0005915453,0.0013604617,0.000076876146],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.01763103,0.0016952342,0.9459396,0.00011589571,0.00054278824,0.00013268688,0.00065001,0.0009922447,0.0011995517,0.00002433306,0.00034043434,0.030736187],"study_design_scores_gemma":[0.038088825,0.013170924,0.9248132,0.0015312473,0.0006713781,0.00015951134,0.002204862,0.0056631616,0.0033768145,0.0005687506,0.009108563,0.0006427678],"about_ca_topic_score_codex":0.00032159587,"about_ca_topic_score_gemma":0.0011176844,"teacher_disagreement_score":0.03009342,"about_ca_system_score_codex":0.00028930328,"about_ca_system_score_gemma":0.00028818048,"threshold_uncertainty_score":0.999851},"labels":[],"label_agreement":null},{"id":"W4386310961","doi":"10.1177/17562848231194395","title":"Handgrip strength and risk of malnutrition are associated with an increased risk of hospitalizations in inflammatory bowel disease patients","year":2023,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Nutrition and Health in Aging","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"","keywords":"Medicine; Inflammatory bowel disease; Malnutrition; Disease; Sarcopenia; Internal medicine","score_opus":0.009753165208807781,"score_gpt":0.27809093972146093,"score_spread":0.26833777451265317,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4386310961","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.998617,0.0004595032,0.00015620053,0.00009500865,0.0000389994,0.0004064333,0.00018827243,0.000030021003,0.000008586505],"genre_scores_gemma":[0.995158,0.0042468724,0.00020437008,0.00012511895,0.000012207416,0.00004528265,0.0001910348,0.0000147739975,0.0000023225282],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99869704,0.00033580753,0.00039363615,0.0001924263,0.00014436155,0.00023672209],"domain_scores_gemma":[0.999143,0.00010558051,0.00039163284,0.00015183394,0.00010224645,0.00010567392],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00026577464,0.00011269575,0.000304039,0.00033541713,0.00003554681,0.000002454444,0.00005074915,0.000051820745,0.000009116917],"category_scores_gemma":[0.00011243567,0.000100847836,0.000024429879,0.00022122194,0.0001906457,0.00013106466,0.000018039917,0.00017043356,3.5394592e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0027569064,0.00071964506,0.9952068,0.0002169036,0.00003835094,0.000008851906,0.00019226191,0.00015300057,0.000012503876,0.000040903633,0.0000023737944,0.00065150246],"study_design_scores_gemma":[0.0081501575,0.0013365179,0.98634326,0.00053303293,0.00008997361,8.0070737e-7,0.00028641438,0.002025526,0.000015730195,0.001154912,0.000014184685,0.000049467584],"about_ca_topic_score_codex":0.00003376229,"about_ca_topic_score_gemma":0.00057789806,"teacher_disagreement_score":0.008863513,"about_ca_system_score_codex":0.00004718227,"about_ca_system_score_gemma":0.000025218218,"threshold_uncertainty_score":0.41124555},"labels":[],"label_agreement":null},{"id":"W4391826282","doi":"10.1177/17562848231222344","title":"Economic impact of inflammatory bowel disease in Catalonia: a population-based analysis","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Health care; Population; Per capita; Ulcerative colitis; Observational study; Crohn's disease; Disease; Environmental health; Internal medicine","score_opus":0.004106138242822802,"score_gpt":0.27484723528338517,"score_spread":0.2707410970405624,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4391826282","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9959422,0.002537393,0.0010589025,0.000040856743,0.000112687914,0.00017948085,0.00010345683,0.000014449366,0.000010592758],"genre_scores_gemma":[0.9993367,0.000091047,0.000068087,0.00008534991,0.000049148177,0.000055236666,0.00028409302,0.000022816857,0.0000075062467],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99865305,0.00015978882,0.0004122344,0.0003865317,0.00006990409,0.00031846884],"domain_scores_gemma":[0.99941915,0.000021353193,0.000090224465,0.00036649866,0.000015840187,0.00008691702],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017739326,0.00019272252,0.00023884131,0.00043077226,0.000014016156,0.000010005523,0.00019182856,0.00007547942,0.00005588726],"category_scores_gemma":[0.000009564006,0.00018635993,0.00027287024,0.00012518726,0.0001309433,0.00001962834,0.00004127378,0.00010156498,0.0000061522323],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012959854,0.000038099348,0.7910702,0.000052742358,0.0001702501,0.000059010767,0.000016136828,0.20664565,0.00027230597,0.000044641438,0.0000023026344,0.00033267323],"study_design_scores_gemma":[0.0006426909,0.00014150745,0.97542894,0.000022709677,0.000103337785,0.0000013545124,0.0000047441836,0.023220662,0.00003149193,0.00024872285,0.000053138887,0.00010068707],"about_ca_topic_score_codex":0.0000829568,"about_ca_topic_score_gemma":0.004293157,"teacher_disagreement_score":0.18435875,"about_ca_system_score_codex":0.00018301091,"about_ca_system_score_gemma":0.00019972921,"threshold_uncertainty_score":0.75995374},"labels":[],"label_agreement":null},{"id":"W4392250424","doi":"10.1177/17562848241230904","title":"Stricture dilation <i>via</i> balloon-assisted endoscopy in Crohn’s disease: approach and intraprocedural outcomes with the single-balloon and double-balloon systems","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Gastrointestinal Bleeding Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Mount Sinai Hospital; St. Michael's Hospital; University of Alberta","funders":"University of Alberta","keywords":"Medicine; Balloon dilation; Retrospective cohort study; Endoscopy; Balloon; Endoscope; Surgery; Crohn's disease; Cohort; Radiology; Internal medicine; Disease","score_opus":0.016515849969582934,"score_gpt":0.2668439261640955,"score_spread":0.2503280761945126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4392250424","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.96679765,0.024629055,0.0033654703,0.0037797326,0.00016022543,0.001086881,0.000009966759,0.00007925183,0.000091750604],"genre_scores_gemma":[0.99746823,0.00072101864,0.00081431493,0.0005560224,0.000058727794,0.00028004363,0.00003340106,0.000034783396,0.000033451026],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99830854,0.0000999269,0.0003513287,0.0005452595,0.00022802777,0.0004669258],"domain_scores_gemma":[0.9993588,0.0001772579,0.00009836053,0.00019997437,0.000036830483,0.0001287811],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00018040524,0.00034704324,0.00050507946,0.00020419659,0.000061047256,0.000081962644,0.000096876574,0.00006573673,0.0000040865007],"category_scores_gemma":[0.0000086320715,0.00020036282,0.000048582944,0.00023628332,0.00027910282,0.00020606474,0.00004547016,0.00035080258,8.423527e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0039112335,0.0004909296,0.984111,0.00042845323,0.00015835419,0.0002477797,0.00028644726,0.00050157466,0.0003573571,0.00053751766,0.000009218872,0.008960134],"study_design_scores_gemma":[0.006175463,0.0018464306,0.98636603,0.0006198282,0.0003561269,0.00072434143,0.00039574865,0.0029265527,0.000020984735,0.00012295089,0.00030595702,0.00013957056],"about_ca_topic_score_codex":0.000038117458,"about_ca_topic_score_gemma":0.0001509246,"teacher_disagreement_score":0.03067057,"about_ca_system_score_codex":0.00014321801,"about_ca_system_score_gemma":0.000031766805,"threshold_uncertainty_score":0.8170559},"labels":[],"label_agreement":null},{"id":"W4393090998","doi":"10.1177/17562848241239606","title":"Accuracy of the Pancolonic Modified Mayo Score in predicting the long-term outcomes of ulcerative colitis: a promising scoring system","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem; Szegedi Tudományegyetem; National Research, Development and Innovation Office; Emberi Eroforrások Minisztériuma","keywords":"Medicine; Ulcerative colitis; Colonoscopy; Internal medicine; Colectomy; Disease; Severity of illness; Retrospective cohort study; Colorectal cancer; Cancer","score_opus":0.01622745357558949,"score_gpt":0.293779502362303,"score_spread":0.2775520487867135,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4393090998","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99562955,0.002173689,0.0008661343,0.000114981514,0.00040360936,0.000704939,0.000020835641,0.000013418861,0.00007286125],"genre_scores_gemma":[0.9994713,0.00017703681,0.000033442655,0.00009653007,0.000055252265,0.00012647426,0.0000049720306,0.000021723374,0.000013256214],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982994,0.0004211244,0.0005090135,0.00030260926,0.00013315023,0.00033467007],"domain_scores_gemma":[0.9992068,0.00009383232,0.00023177765,0.00039857978,0.00004451218,0.000024494253],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00040412642,0.0001792548,0.00027639105,0.00007075567,0.000045392117,0.000012158496,0.00039253058,0.00007924086,0.0000026467837],"category_scores_gemma":[0.000058955913,0.00011599495,0.00011332483,0.000114956114,0.00031067434,0.000021319958,0.00016913687,0.0002059666,4.3446502e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001246595,0.000056241348,0.9860344,0.0005003769,0.000109296234,0.00003470352,0.0006391299,0.0026229285,0.005598525,0.00053501816,6.777667e-7,0.0026221015],"study_design_scores_gemma":[0.00095392903,0.0001895352,0.993967,0.0006178138,0.000042406624,0.00003256414,0.0003856397,0.001232196,0.002349478,0.00014547016,0.0000120624745,0.00007193341],"about_ca_topic_score_codex":0.000009342013,"about_ca_topic_score_gemma":0.00079974,"teacher_disagreement_score":0.007932565,"about_ca_system_score_codex":0.00007252541,"about_ca_system_score_gemma":0.00010588567,"threshold_uncertainty_score":0.47301367},"labels":[],"label_agreement":null},{"id":"W4399046147","doi":"10.1177/17562848241254267","title":"Impact of rifaximin use in infections and mortality in patients with decompensated cirrhosis and hepatic encephalopathy","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease and Transplantation","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Rifaximin; Internal medicine; Hepatic encephalopathy; Cirrhosis; Spontaneous bacterial peritonitis; Cohort; Liver disease; Gastroenterology; Model for End-Stage Liver Disease; Pneumonia; Mortality rate; Antibiotics; Liver transplantation","score_opus":0.010454501987918665,"score_gpt":0.29505882608773126,"score_spread":0.2846043240998126,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399046147","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99874264,0.0006748125,0.00022866437,0.000014807553,0.000028950924,0.00027272518,0.000020401536,0.000009542304,0.000007430374],"genre_scores_gemma":[0.99900883,0.00082404894,0.0000689917,0.000045073168,0.0000035118062,0.000018548995,0.000022883734,0.0000074148415,6.94862e-7],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9993072,0.000083271014,0.00020510163,0.00018429487,0.000064088475,0.0001560504],"domain_scores_gemma":[0.9997588,0.00007518534,0.000032356067,0.00007799308,0.000017872535,0.00003780526],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007096268,0.00009935057,0.00022809855,0.0002441047,0.0000075217695,0.0000055821047,0.000019094543,0.000030731673,0.00001253431],"category_scores_gemma":[0.000002937718,0.000075715325,0.000019306046,0.0001574099,0.00011382119,0.0002475792,0.000007676628,0.00011104069,2.7334352e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0012877422,0.00027314987,0.9958133,0.0001236147,0.00008692008,0.000027994225,0.0005970121,0.000087168235,0.000041753156,0.00001535068,3.4972754e-8,0.0016459781],"study_design_scores_gemma":[0.002842926,0.0017282757,0.99411595,0.0002314877,0.00012094943,0.000012031626,0.000028021634,0.00063911633,0.000008859319,0.0002335443,5.6732614e-7,0.0000382913],"about_ca_topic_score_codex":0.0003190379,"about_ca_topic_score_gemma":0.002565253,"teacher_disagreement_score":0.0022462152,"about_ca_system_score_codex":0.00004419635,"about_ca_system_score_gemma":0.000020739943,"threshold_uncertainty_score":0.30875814},"labels":[],"label_agreement":null},{"id":"W4401433256","doi":"10.1177/17562848241265776","title":"Patient preferences for adalimumab in inflammatory bowel disease: a nationwide study from the GETAID","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"","keywords":"Adalimumab; Medicine; Inflammatory bowel disease; Tolerability; Internal medicine; Crohn's disease; Disease; Gastroenterology; Adverse effect","score_opus":0.008517368546243338,"score_gpt":0.2671136693772876,"score_spread":0.25859630083104423,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401433256","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9887603,0.007657289,0.0016713808,0.00025264794,0.0004143367,0.0010901702,0.00009530898,0.000024069299,0.00003448226],"genre_scores_gemma":[0.99756986,0.00033769335,0.00012407609,0.000838888,0.00014716896,0.00084969774,0.00008836357,0.000027899965,0.000016350343],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9982988,0.0003292726,0.00038068157,0.0004929331,0.00014290262,0.00035541362],"domain_scores_gemma":[0.99938214,0.00009470885,0.00007228943,0.00036231414,0.000037435657,0.000051090778],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022297929,0.0002096979,0.00014558839,0.000062286235,0.000050466304,0.00003461607,0.00029738137,0.000060762282,0.000021236958],"category_scores_gemma":[0.000046662335,0.00016091032,0.00008020835,0.000054281783,0.00013787994,0.000027609849,0.00010122406,0.0001433924,0.000005051736],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.003907534,0.0002822686,0.98502356,0.0000516542,0.000105101855,0.00008397403,0.00097606704,0.0021726666,0.0005750906,0.00023354928,0.00004671513,0.0065417956],"study_design_scores_gemma":[0.0022682473,0.00088245346,0.97317076,0.00007983997,0.0000617724,0.0000028667216,0.0011204424,0.0011179292,0.00009739385,0.008342971,0.0126531925,0.0002021457],"about_ca_topic_score_codex":0.000009861858,"about_ca_topic_score_gemma":0.0019515423,"teacher_disagreement_score":0.012606477,"about_ca_system_score_codex":0.000036378064,"about_ca_system_score_gemma":0.00008786056,"threshold_uncertainty_score":0.6561732},"labels":[],"label_agreement":null},{"id":"W4403447964","doi":"10.1177/17562848241290346","title":"A retrospective real-world study on the safety and efficacy of budesonide orodispersible tablets for the induction therapy of eosinophilic oesophagitis","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Eosinophilic Esophagitis","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Eosinophilic esophagitis; Budesonide; Gastroenterology; Induction therapy; Internal medicine; Retrospective cohort study; Corticosteroid; Disease","score_opus":0.026085919811959308,"score_gpt":0.3290994750372087,"score_spread":0.3030135552252494,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403447964","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.98023885,0.0115050115,0.00054083444,0.004445178,0.00038750467,0.002519402,0.000036074376,0.000040845458,0.0002862712],"genre_scores_gemma":[0.99175596,0.007209132,0.00009436248,0.0005192684,0.00014231906,0.00015001609,0.0000048937754,0.000040253253,0.00008378962],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99813116,0.00023790792,0.0005495855,0.00046074236,0.00026357468,0.00035702405],"domain_scores_gemma":[0.9981511,0.0009989847,0.00018247617,0.00052785286,0.00009956927,0.00004001266],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007384888,0.0002483515,0.0005928014,0.00026051668,0.0000930002,0.000012003652,0.00021593904,0.00006302795,0.000049907296],"category_scores_gemma":[0.00007153522,0.00014416545,0.000114837734,0.00045024732,0.00064937246,0.000118688564,0.000050579227,0.0003881741,0.0000012208644],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.022497158,0.0022276337,0.7927204,0.00022746625,0.001462992,0.000047711423,0.008928821,0.0002779626,0.008421236,0.01954947,0.000036869293,0.14360228],"study_design_scores_gemma":[0.0050331224,0.009588284,0.97873265,0.000247675,0.00017808593,0.00006886785,0.001118602,0.00031539184,0.0011751002,0.0025526586,0.0008992608,0.00009028801],"about_ca_topic_score_codex":0.00008236011,"about_ca_topic_score_gemma":0.00033163893,"teacher_disagreement_score":0.18601225,"about_ca_system_score_codex":0.00013987208,"about_ca_system_score_gemma":0.000046824098,"threshold_uncertainty_score":0.5878897},"labels":[],"label_agreement":null},{"id":"W4403455365","doi":"10.1177/17562848241290636","title":"Outcomes of treatment cessation after switching to subcutaneous vedolizumab treatment in inflammatory bowel diseases","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"Szent-Györgyi Albert Orvostudományi Kar, Szegedi Tudományegyetem; National Research, Development and Innovation Office; Nemzeti Kutatási, Fejlesztési és Innovaciós Alap; Bristol-Myers Squibb; Eli Lilly and Company; Szegedi Tudományegyetem; Emberi Eroforrások Minisztériuma; Celltrion; Teva Pharmaceutical Industries; Gilead Sciences; Amgen; Pfizer; Horizon 2020 Framework Programme","keywords":"Vedolizumab; Medicine; Inflammatory bowel disease; Internal medicine; Gastroenterology; Disease","score_opus":0.005912891383417481,"score_gpt":0.2692807805838435,"score_spread":0.26336788920042603,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403455365","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9954958,0.002867046,0.00066296064,0.00012229412,0.0002661887,0.0004756153,0.000048471367,0.000023033357,0.00003860024],"genre_scores_gemma":[0.99843967,0.00064094714,0.0001271703,0.00023935792,0.00006791539,0.0003654932,0.000035368466,0.000032909742,0.000051147297],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99853975,0.0001590783,0.00040025671,0.00043362277,0.00009009007,0.0003772338],"domain_scores_gemma":[0.9994753,0.000030466907,0.00006197287,0.0003282137,0.00001990213,0.00008414482],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000065860135,0.00027223097,0.00027418305,0.00021335742,0.000017665207,0.000014379741,0.00013362728,0.00007947284,0.000023168779],"category_scores_gemma":[0.00000994052,0.00022730566,0.000120793324,0.00006213298,0.000067698995,0.00001923323,0.000047111447,0.00005472954,0.000009079222],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.004597149,0.00025524577,0.9661702,0.00006591593,0.000120332355,0.00052784255,0.0005270727,0.0039578164,0.0045946636,0.00007780829,0.0000013126336,0.019104667],"study_design_scores_gemma":[0.0022163172,0.0029752373,0.9898802,0.00007336752,0.00007949064,0.000040432355,0.00015296717,0.0004358122,0.000795459,0.0005510729,0.0025839426,0.00021571995],"about_ca_topic_score_codex":0.000018940646,"about_ca_topic_score_gemma":0.0015343466,"teacher_disagreement_score":0.023710007,"about_ca_system_score_codex":0.00026440644,"about_ca_system_score_gemma":0.00008958401,"threshold_uncertainty_score":0.92692554},"labels":[],"label_agreement":null},{"id":"W4403778739","doi":"10.1177/17562848241272995","title":"Advanced combination therapy: is it the best way to break the therapeutic ceiling?","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Montreal General Hospital; McGill University Health Centre","funders":"","keywords":"Medicine; Ulcerative colitis; Therapeutic approach; Disease; Refractory (planetary science); Vedolizumab; Inflammatory bowel disease; Intensive care medicine; Therapeutic effect; Clinical trial; Biologic Agents; Internal medicine","score_opus":0.024422860439279014,"score_gpt":0.3410506527082592,"score_spread":0.3166277922689802,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403778739","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00218188,0.99192166,0.0004534127,0.0016266463,0.0011589833,0.002248864,0.00008312735,0.0000331762,0.00029222417],"genre_scores_gemma":[0.011882469,0.9762234,0.000041896088,0.00931933,0.00037447247,0.0011709282,0.00011046122,0.00015843363,0.0007186162],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99598897,0.0009620735,0.00087132497,0.001016186,0.0003049933,0.0008564342],"domain_scores_gemma":[0.9979151,0.00011178294,0.00035276797,0.0014117233,0.00010001858,0.00010859915],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00067047967,0.0008408721,0.0009290484,0.0001851354,0.0001944321,0.00007697916,0.0015406718,0.0003590226,0.00005943049],"category_scores_gemma":[0.00002619733,0.00047294982,0.0005715634,0.0003086809,0.00044453255,0.000018625637,0.00034281082,0.00074465194,0.00023664633],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000673093,0.00019263357,0.0001588241,0.00089990126,0.0005124559,0.0000448354,0.00033246796,0.00006955622,0.00004793562,0.00038426643,0.0003573421,0.9963267],"study_design_scores_gemma":[0.0007016491,0.0007567852,0.00011341808,0.00080180774,0.00044721912,0.00010924698,0.00020385452,0.000020893967,0.000014012858,0.00067774643,0.995813,0.00034032844],"about_ca_topic_score_codex":0.0000034758657,"about_ca_topic_score_gemma":0.00017200853,"teacher_disagreement_score":0.99598634,"about_ca_system_score_codex":0.000107981636,"about_ca_system_score_gemma":0.00014382867,"threshold_uncertainty_score":0.9997722},"labels":[],"label_agreement":null},{"id":"W4404194478","doi":"10.1177/17562848241293643","title":"Non-serious adverse events in patients with ulcerative colitis receiving etrasimod: an analysis of the phase II OASIS and phase III ELEVATE UC 52 and ELEVATE UC 12 clinical trials","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Genentech; UCB Pharma; Sun Pharma; Astellas Pharma; Celltrion; Bristol-Myers Squibb; Eli Lilly and Company; AstraZeneca; Celltrion Healthcare; Gilead Sciences; GlaxoSmithKline; Tillotts Pharma; Amgen; Dr. Falk Pharma; Pfizer; Celgene","keywords":"Medicine; Ulcerative colitis; Adverse effect; Phases of clinical research; Phase (matter); Internal medicine; Clinical trial; Gastroenterology; Intensive care medicine; Disease","score_opus":0.01593308882847572,"score_gpt":0.35102174349784043,"score_spread":0.3350886546693647,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404194478","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99771893,0.00027012223,0.00088485214,0.000048152935,0.00016731788,0.0007248129,0.00016843811,0.000008612794,0.000008767955],"genre_scores_gemma":[0.9987256,0.00056862656,0.00012797407,0.00031540205,0.00004418638,0.00006842157,0.00011139572,0.000025500098,0.000012927261],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9967588,0.0012026095,0.00088618294,0.00061394396,0.00015344744,0.00038497013],"domain_scores_gemma":[0.99902713,0.000094523406,0.00032625557,0.0003752371,0.00006439331,0.000112464775],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0013348358,0.00027216363,0.00069510675,0.00020872129,0.000072844174,0.000008156755,0.00020083819,0.00013908671,0.000019444771],"category_scores_gemma":[0.00008258831,0.00020212801,0.00014410321,0.00021263894,0.00037758026,0.000046855712,0.00013235061,0.00021800118,2.3382788e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.025617847,0.0010044718,0.94870657,0.000047000478,0.00086330355,0.000025882939,0.00044946195,0.00045687455,0.0012586955,0.000021023901,0.000001601435,0.021547273],"study_design_scores_gemma":[0.019651514,0.0044936086,0.97120345,0.0000754175,0.0006691428,0.0000036339022,0.0001665527,0.0030624159,0.00024463574,0.00013189294,0.0001300151,0.00016771085],"about_ca_topic_score_codex":0.000013606752,"about_ca_topic_score_gemma":0.0022405346,"teacher_disagreement_score":0.022496898,"about_ca_system_score_codex":0.000034148477,"about_ca_system_score_gemma":0.00005826117,"threshold_uncertainty_score":0.8242541},"labels":[],"label_agreement":null},{"id":"W4404431078","doi":"10.1177/17562848241276334","title":"Modernizing metabolic dysfunction-associated steatotic liver disease diagnostics: the progressive shift from liver biopsy to noninvasive techniques","year":2024,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Liver Disease Diagnosis and Treatment","field":"Medicine","cited_by":21,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"London Health Sciences Centre; Western University","funders":"Fondo Nacional de Desarrollo Científico y Tecnológico","keywords":"Medicine; Liver biopsy; Biopsy; Gold standard (test); Radiology; Modalities; Liver disease; Review article; Disease; Intensive care medicine; Pathology; Internal medicine","score_opus":0.032745013237926876,"score_gpt":0.33499491708931933,"score_spread":0.30224990385139244,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404431078","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001995988,0.99185264,0.0003212581,0.00038413017,0.0006873391,0.0039912006,0.0005454736,0.00019610614,0.000025860685],"genre_scores_gemma":[0.023953047,0.9691798,0.00027491112,0.0013565801,0.00042230563,0.004121519,0.0005008432,0.00015038917,0.00004062405],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99621916,0.00061998796,0.0008165925,0.0011245856,0.00041138177,0.0008082952],"domain_scores_gemma":[0.9975499,0.0007575803,0.00040366576,0.00080669246,0.00010729647,0.00037487925],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001717487,0.00092356844,0.0022000975,0.000422954,0.00011883236,0.00008154228,0.00044741627,0.00025063055,0.0001493771],"category_scores_gemma":[0.000115381976,0.0005603119,0.00072524376,0.0003964103,0.00029385946,0.00015892957,0.00029448242,0.00075740117,0.00024967353],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000843471,0.0025033108,0.01635347,0.004356962,0.005065536,0.0061818664,0.0009183037,0.000017578574,2.0431112e-7,0.0003459277,0.00017444303,0.96323895],"study_design_scores_gemma":[0.003868486,0.0041847364,0.022517214,0.075960964,0.088491224,0.00041102056,0.00023290397,0.00026647642,0.000009819464,0.0031826512,0.79923105,0.0016434736],"about_ca_topic_score_codex":0.00008235738,"about_ca_topic_score_gemma":0.00011202616,"teacher_disagreement_score":0.9615955,"about_ca_system_score_codex":0.0004626985,"about_ca_system_score_gemma":0.00026610662,"threshold_uncertainty_score":0.9996848},"labels":[],"label_agreement":null},{"id":"W4404555515","doi":"10.1177/17562848241299739","title":"Bowel preparation efficacy and discomfort of 2 L polyethylene glycol combined with linaclotide versus 3 L polyethylene glycol: a noninferiority, prospective, multicenter, randomized controlled trial","year":2024,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Regimen; Randomized controlled trial; Tolerability; Colonoscopy; PEG ratio; Internal medicine; Gastroenterology; Bloating; Polyethylene glycol; Surgery; Adverse effect; Nausea; Colorectal cancer; Chemistry","score_opus":0.009608364835663408,"score_gpt":0.31178746396981133,"score_spread":0.3021790991341479,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404555515","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9782453,0.005143772,0.007778808,0.00030598044,0.0010781593,0.007035223,0.0000071887703,0.00013194335,0.0002735904],"genre_scores_gemma":[0.99659973,0.0009972111,0.00085581513,0.00008334172,0.00016470141,0.0011634334,0.000015986128,0.00003665788,0.00008309274],"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","domain_scores_codex":[0.9976493,0.0003773797,0.00077383354,0.00052146346,0.0002874626,0.00039054223],"domain_scores_gemma":[0.9985565,0.000759972,0.00026765888,0.00025259375,0.00006782121,0.00009544834],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00060481805,0.00032847596,0.0016568236,0.000294008,0.00005778555,0.0000289711,0.000090056295,0.00011418,0.000023362123],"category_scores_gemma":[0.000103698505,0.0002329828,0.00020436248,0.00021919921,0.0005018184,0.00022662355,0.000053764117,0.00036785784,8.478172e-7],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.98963386,0.00050550175,0.004844502,0.00012951622,0.0006052911,0.00002668654,0.00049460516,0.00015573262,0.0009926953,0.00013298873,8.4833806e-7,0.0024777513],"study_design_scores_gemma":[0.9275221,0.05862457,0.0027978332,0.00030976703,0.00068758446,0.00006226909,0.00009793582,0.008569003,0.0009488023,0.00017027748,0.00007765029,0.0001321796],"about_ca_topic_score_codex":0.000077669065,"about_ca_topic_score_gemma":0.0006418603,"teacher_disagreement_score":0.062111754,"about_ca_system_score_codex":0.00014402588,"about_ca_system_score_gemma":0.0001014125,"threshold_uncertainty_score":0.9500763},"labels":[],"label_agreement":null},{"id":"W4407613426","doi":"10.1177/17562848251314827","title":"Exploring the connection between erythrocyte membrane fatty acid composition and oxidative stress in patients undergoing the Crohn’s disease Therapeutic Diet Intervention (CD-TDI)","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Fatty Acid Research and Health","field":"Nursing","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of British Columbia, Okanagan Campus; University of British Columbia","funders":"","keywords":"Medicine; Oxidative stress; Polyunsaturated fatty acid; Crohn's disease; Internal medicine; Malondialdehyde; Inflammatory bowel disease; Fatty acid; Endocrinology; Disease; Biochemistry; Chemistry","score_opus":0.037164963011115826,"score_gpt":0.3225490004525236,"score_spread":0.2853840374414078,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407613426","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9827619,0.0019367042,0.008065849,0.0056368727,0.0006043533,0.00091314106,0.000020638143,0.000037306465,0.00002321431],"genre_scores_gemma":[0.99731314,0.0013107053,0.0000663028,0.0009672719,0.00006212265,0.00020737326,0.00005172411,0.00001869736,0.000002644954],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9970582,0.0012396954,0.00047744205,0.0004040064,0.00021921708,0.00060144695],"domain_scores_gemma":[0.998855,0.0005544535,0.00016852611,0.00029583654,0.000056868474,0.00006930229],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005323609,0.0002325888,0.00031899058,0.00025286464,0.00034947926,0.00005592864,0.0002911541,0.000051312643,0.000008884805],"category_scores_gemma":[0.00004190686,0.00016125316,0.000072034556,0.00028668693,0.0004078399,0.0006007955,0.00012454684,0.00058353064,0.0000022857375],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.012896791,0.00035915416,0.9178848,0.00026471278,0.00008735681,0.0000040093105,0.0012269386,0.0005787742,0.000691382,0.00031829314,0.0000017580849,0.065686025],"study_design_scores_gemma":[0.0035636448,0.0011965991,0.9872925,0.0004321015,0.000056105182,9.545951e-7,0.0012086814,0.00053686544,0.0025427195,0.00301986,0.000054741085,0.00009521744],"about_ca_topic_score_codex":0.000070123155,"about_ca_topic_score_gemma":0.002485788,"teacher_disagreement_score":0.0694077,"about_ca_system_score_codex":0.00029055242,"about_ca_system_score_gemma":0.000019757152,"threshold_uncertainty_score":0.6575713},"labels":[],"label_agreement":null},{"id":"W4407667477","doi":"10.1177/17562848251319807","title":"“Simpleness”: a qualitative description study exploring patient perspectives on the barriers and facilitators of using digital health tools to self-manage inflammatory bowel disease","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary; University of Alberta","funders":"Alberta Innovates - Health Solutions","keywords":"Thematic analysis; Medicine; Usability; Digital health; Qualitative research; Health care; Credibility; Disease management; Patient portal; Self-management; Nursing; Knowledge management; Medical education; Health management system; Alternative medicine; Computer science","score_opus":0.02399174349080221,"score_gpt":0.3125680524862257,"score_spread":0.2885763089954235,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407667477","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99554783,0.0007255981,0.002407959,0.00017888601,0.00011242916,0.00092902035,0.000066381486,0.000014285692,0.000017587501],"genre_scores_gemma":[0.99893284,0.00013294749,0.00009344089,0.0005852258,0.000014624814,0.00021673836,0.000006277811,0.000014132501,0.0000037713528],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9981372,0.00062299863,0.00037302342,0.00041895025,0.0001304807,0.00031737052],"domain_scores_gemma":[0.9992804,0.000064289816,0.00013363633,0.00033397417,0.00006143132,0.00012627801],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00035462662,0.00020437653,0.00020387594,0.0001506462,0.00010882996,0.000024643776,0.00016629697,0.00002827884,0.000003094839],"category_scores_gemma":[0.00015283565,0.00017229607,0.00005652714,0.00008780401,0.00019084745,0.000051090166,0.00014512411,0.0000991827,5.1895415e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.010350606,0.0006093786,0.8927523,0.00023789711,0.0003736349,0.000034008637,0.07962237,0.0062718014,0.0013476948,0.0022435335,0.000009882734,0.006146914],"study_design_scores_gemma":[0.0025557547,0.0032032102,0.56590825,0.00018269966,0.00006336893,0.0000022956544,0.4251509,0.00033077053,0.00016344429,0.0012894748,0.0008320792,0.00031776226],"about_ca_topic_score_codex":0.0000043976347,"about_ca_topic_score_gemma":0.000057621797,"teacher_disagreement_score":0.34552854,"about_ca_system_score_codex":0.00010534667,"about_ca_system_score_gemma":0.00008850753,"threshold_uncertainty_score":0.70260304},"labels":[],"label_agreement":null},{"id":"W4407895536","doi":"10.1177/17562848251321915","title":"Artificial intelligence to revolutionize IBD clinical trials: a comprehensive review","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Artificial Intelligence in Healthcare and Education","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; Lawson Health Research Institute; Western University","funders":"","keywords":"Clinical trial; Medicine; Data sharing; Transformative learning; Precision medicine; Big data; Artificial intelligence; Data science; Alternative medicine; Computer science; Psychology; Data mining; Pathology","score_opus":0.5441135652873395,"score_gpt":0.6230514199549625,"score_spread":0.07893785466762304,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407895536","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000007782941,0.9685506,0.020707315,0.0031601642,0.0028107266,0.0045814146,0.000024968918,0.000060493396,0.0000964976],"genre_scores_gemma":[0.000036192363,0.9837972,0.0017550616,0.012451387,0.0008705274,0.00086661,0.00010624203,0.000041443487,0.000075352335],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98821324,0.0042629545,0.0054799905,0.0010061689,0.0002702043,0.00076741667],"domain_scores_gemma":[0.99312794,0.004267957,0.0010778091,0.000907369,0.00032949718,0.0002894304],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0042560822,0.0005806342,0.005918371,0.00057966023,0.00008266258,0.000013941732,0.00046012513,0.000489787,0.00023535088],"category_scores_gemma":[0.0034949963,0.00047010992,0.0009989069,0.0009245381,0.00029967376,0.000095131014,0.00013154403,0.0013750475,0.00031336158],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00043810133,0.00026311306,0.00014920766,0.038983323,0.00011378185,0.000017078582,0.000035047837,0.0000038005205,6.643797e-8,0.00038361625,0.00026253195,0.95935035],"study_design_scores_gemma":[0.000024965058,0.0011866542,0.000011305712,0.088795,0.0012781739,0.000108186345,0.0000930758,0.000014702753,0.0000010268645,0.0036829673,0.90460885,0.00019508069],"about_ca_topic_score_codex":0.000022743103,"about_ca_topic_score_gemma":0.00009869341,"teacher_disagreement_score":0.95915526,"about_ca_system_score_codex":0.0003838752,"about_ca_system_score_gemma":0.00083166006,"threshold_uncertainty_score":0.99977505},"labels":[],"label_agreement":null},{"id":"W4407985628","doi":"10.1177/17562848251323004","title":"Tryptophan metabolites profile predict remission with dietary therapy in pediatric Crohn’s disease","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"Université François-Rabelais; Amsterdam University Medical Centers; European Crohn's and Colitis Organisation; Mount Saint Vincent University; Pfizer","keywords":"Medicine; Gastroenterology; Internal medicine; Randomized controlled trial; Tryptophan; Feces; Crohn's disease; Receiver operating characteristic; Area under the curve; Inflammatory bowel disease; Disease; Biology; Biochemistry","score_opus":0.005902273541860662,"score_gpt":0.25664693084760515,"score_spread":0.25074465730574447,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4407985628","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9849767,0.012946,0.0007886976,0.00018135538,0.00017099286,0.00056642515,0.000021810722,0.000024333414,0.00032367825],"genre_scores_gemma":[0.99075574,0.0071029677,0.0003927112,0.0011152982,0.00011932574,0.00025696584,0.0000716813,0.000026014915,0.00015927662],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99821746,0.00028714509,0.00033807897,0.0005380418,0.00012290516,0.00049638376],"domain_scores_gemma":[0.9992875,0.000019297866,0.00010111085,0.00044166314,0.000044473723,0.00010599455],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00017608923,0.00026994973,0.0002545556,0.00020356024,0.000045262517,0.000010599489,0.00030337356,0.0000965472,0.000034936995],"category_scores_gemma":[0.000024621915,0.00022191202,0.00006980934,0.0001781643,0.00016164343,0.000022591197,0.00008406428,0.00017660334,0.0000026327673],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.013670123,0.0003017441,0.9724671,0.00007024709,0.000036240996,0.00016566679,0.000034679317,0.0005264663,0.0029390608,0.000051070325,0.000028241888,0.00970935],"study_design_scores_gemma":[0.0032931184,0.00039415358,0.99277186,0.000038400914,0.00003198506,0.0000036754068,0.000035054294,0.00014701266,0.00061409967,0.00064022234,0.0018895351,0.00014088256],"about_ca_topic_score_codex":0.0000026659015,"about_ca_topic_score_gemma":0.000109696055,"teacher_disagreement_score":0.02030475,"about_ca_system_score_codex":0.000029987375,"about_ca_system_score_gemma":0.00012543364,"threshold_uncertainty_score":0.90493095},"labels":[],"label_agreement":null},{"id":"W4410589534","doi":"10.1177/17562848251335824","title":"MASLD and liver fibrosis in patients with psoriasis receiving IL-17 or IL-23 inhibitors: a systematic review","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":10,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Amgen","keywords":"Medicine; Internal medicine; Randomized controlled trial; Psoriasis; Cohort study; Systematic review; Cohort; Observational study; Clinical trial; Relative risk; MEDLINE; Immunology; Confidence interval","score_opus":0.014594544777399226,"score_gpt":0.26961400377438827,"score_spread":0.255019458996989,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4410589534","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00057594496,0.9950349,0.00003143833,0.000030555584,0.0005543602,0.003477554,0.00020670239,0.00004664577,0.000041917458],"genre_scores_gemma":[0.00044302212,0.996783,0.0001477011,0.00034791193,0.000027929036,0.0013355135,0.00034284362,0.000055108925,0.0005169317],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9947517,0.002038319,0.0014228415,0.00090476597,0.0000854411,0.0007969216],"domain_scores_gemma":[0.997526,0.00090331153,0.00082186155,0.0006516571,0.000059693248,0.000037487098],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00049756235,0.0008745992,0.004329675,0.0005799079,0.00008790367,0.000015862895,0.00046608475,0.00051309826,0.000101888145],"category_scores_gemma":[0.00011165005,0.00056257925,0.00026744776,0.000507468,0.00024964826,0.00020618961,0.00018150148,0.0005363949,0.000044155637],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.001264767,0.0004290773,0.0057127066,0.53618234,0.0011028942,0.000034621786,0.0001452387,6.7803603e-7,5.399613e-7,0.000012695573,0.00006108802,0.45505336],"study_design_scores_gemma":[0.0055111563,0.0024965368,0.0009565564,0.8846411,0.007314656,0.00014282223,0.000057729547,3.535189e-7,0.0000030015415,0.00003066175,0.098162495,0.0006829101],"about_ca_topic_score_codex":0.000010770357,"about_ca_topic_score_gemma":0.0003212769,"teacher_disagreement_score":0.45437044,"about_ca_system_score_codex":0.00022135903,"about_ca_system_score_gemma":0.00009836473,"threshold_uncertainty_score":0.99968255},"labels":[],"label_agreement":null},{"id":"W4411023152","doi":"10.1177/17562848251339878","title":"Progressing or preserving, disease extent evolution in hospitalized patients with ulcerative colitis in China: a real-world study","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Ulcerative colitis; Internal medicine; Disease; Proportional hazards model; Retrospective cohort study; Cohort; Logistic regression; Proctitis; Gastroenterology","score_opus":0.004912037482061353,"score_gpt":0.2800623872286377,"score_spread":0.2751503497465763,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411023152","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9972594,0.00026257435,0.0004932806,0.000073534735,0.000108900305,0.0016215959,0.0000148241725,0.000014082098,0.00015182058],"genre_scores_gemma":[0.99876434,0.000081317914,0.00015332049,0.00016783083,0.000020825171,0.0006271949,0.000044571465,0.00002052863,0.00012010329],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99789155,0.00056656223,0.00039690835,0.000533335,0.0001364957,0.00047518086],"domain_scores_gemma":[0.9993665,0.000012614527,0.00013249178,0.00036493898,0.0000562216,0.000067208595],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002003875,0.00024059354,0.00027316087,0.0002563123,0.00004568876,0.00001616425,0.00024128449,0.000050054165,0.000014458362],"category_scores_gemma":[0.000036181384,0.00020042495,0.000034779372,0.00023779755,0.00016846939,0.000033049324,0.00014805418,0.00015075863,5.733587e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.030226398,0.0013990742,0.96587044,0.00005021923,0.000038731625,0.00013000758,0.0002114353,0.0009410466,0.000016101518,0.000059750007,0.0000031663992,0.001053602],"study_design_scores_gemma":[0.008097927,0.0010563823,0.9896536,0.0001523768,0.00002381597,4.683091e-7,0.0001605535,0.00024460984,0.000006794043,0.00041467306,0.00006401053,0.00012482812],"about_ca_topic_score_codex":0.000053442705,"about_ca_topic_score_gemma":0.030485632,"teacher_disagreement_score":0.030432189,"about_ca_system_score_codex":0.0001850743,"about_ca_system_score_gemma":0.00012479676,"threshold_uncertainty_score":0.9872055},"labels":[],"label_agreement":null},{"id":"W4411244591","doi":"10.1177/17562848251342340","title":"Role of medico-administrative database in the selection of the target population in colorectal cancer screening program","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Colorectal Cancer Screening and Detection","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Population; Family medicine; Colorectal cancer; Colonoscopy; Descriptive statistics; MEDLINE; Cancer; Environmental health; Internal medicine; Statistics","score_opus":0.01667958311375903,"score_gpt":0.3483663490319294,"score_spread":0.33168676591817037,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4411244591","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.99609524,0.0012690533,0.0010010923,0.00055219285,0.0001236955,0.0007481422,0.000008776223,0.000012495033,0.00018930579],"genre_scores_gemma":[0.99851125,0.00012088198,0.00087055436,0.00020898817,0.000023924078,0.00024208368,0.000012326822,0.000005570199,0.000004444157],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9987518,0.00030058023,0.00038533128,0.0001913811,0.0001640286,0.00020686918],"domain_scores_gemma":[0.9995474,0.00010290995,0.00017438053,0.000121442354,0.000041237916,0.000012634969],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037995976,0.00010686735,0.00028226938,0.00019895966,0.000026585492,0.0000025060824,0.00013097504,0.00006187687,0.000014069815],"category_scores_gemma":[0.000045857683,0.00007137686,0.000047931982,0.00065607677,0.00015655044,0.000089157664,0.000030979954,0.00032625181,4.869469e-8],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.009831219,0.00022778998,0.9363221,0.000045849436,0.000021982281,0.0000010186701,0.00057107134,0.0009687953,0.0034776796,0.0000911845,0.0000010360069,0.048440266],"study_design_scores_gemma":[0.0017992652,0.002572008,0.98130625,0.00028215113,0.000031826756,0.000015504374,0.0011495353,0.006582502,0.0054330714,0.0006174331,0.00017364818,0.000036827834],"about_ca_topic_score_codex":0.00073154084,"about_ca_topic_score_gemma":0.015593383,"teacher_disagreement_score":0.04840344,"about_ca_system_score_codex":0.00009848486,"about_ca_system_score_gemma":0.00006106148,"threshold_uncertainty_score":0.8701474},"labels":[],"label_agreement":null},{"id":"W4413307108","doi":"10.1177/17562848251363703","title":"Asia Pacific association of gastroenterology consensus statements on histopathological evaluation of inflammatory bowel diseases","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Inflammatory bowel disease; Gastroenterology; Internal medicine; Inflammatory Bowel Diseases; Ulcerative colitis; Asia pacific; Association (psychology); Pathology; General surgery; Disease","score_opus":0.010591064293821666,"score_gpt":0.3067016564120919,"score_spread":0.29611059211827023,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413307108","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.997226,0.0005359355,0.0006345629,0.00017050459,0.0003616062,0.00047518604,0.00007219169,0.000011040049,0.00051298225],"genre_scores_gemma":[0.9991021,0.0002062242,0.00011407071,0.00029702907,0.000028497256,0.00010150147,0.00007289296,0.000013343791,0.00006430666],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99707973,0.001167486,0.00066839904,0.00039664193,0.00030676785,0.00038098096],"domain_scores_gemma":[0.99872583,0.00005519611,0.000516985,0.00038905969,0.00026534565,0.000047592584],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009011596,0.00021167703,0.00033970067,0.0002023687,0.00003120057,0.0000031575294,0.00022748516,0.0001519726,0.000031096315],"category_scores_gemma":[0.00020325172,0.00021135587,0.00011359433,0.000065000146,0.00029192842,0.000010758504,0.00008238583,0.00013059509,0.000002290219],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008583206,0.00039612735,0.9757636,0.00007304959,0.000107265645,0.000010922786,0.00003383814,0.003022477,0.009967298,0.00034228613,0.00009294066,0.0016069665],"study_design_scores_gemma":[0.004932629,0.0014827629,0.9886747,0.000055729808,0.000164514,0.000003895427,0.00018172659,0.00043917002,0.0013155016,0.00202315,0.0006253147,0.000100912264],"about_ca_topic_score_codex":8.8937907e-7,"about_ca_topic_score_gemma":0.00007870723,"teacher_disagreement_score":0.012911071,"about_ca_system_score_codex":0.00016771,"about_ca_system_score_gemma":0.00010508452,"threshold_uncertainty_score":0.86188424},"labels":[],"label_agreement":null},{"id":"W4414828950","doi":"10.1177/17562848251358168","title":"Adalimumab around the world: comparative analysis of products characteristics and patient support systems","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Biosimilars and Bioanalytical Methods","field":"Immunology and Microbiology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Adalimumab; Usability; Biosimilar; Dosing; MEDLINE; Patient safety; Patient satisfaction; Psychological intervention","score_opus":0.04039737541785968,"score_gpt":0.36537673269169263,"score_spread":0.324979357273833,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414828950","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00016104306,0.9973076,0.00022385191,0.00011126252,0.0008369597,0.0008059878,0.00030283778,0.00001245422,0.00023798698],"genre_scores_gemma":[0.008470662,0.9903924,0.00009776185,0.0002751148,0.000022609353,0.00011888808,0.000149301,0.000010832839,0.0004624578],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9960408,0.001727892,0.0011646874,0.00055327074,0.000054244352,0.00045906627],"domain_scores_gemma":[0.9975988,0.00096200325,0.0008122215,0.000517931,0.00008978026,0.00001924499],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00044450525,0.00043782816,0.0032935694,0.0007082981,0.00006736823,0.000013304927,0.00039874105,0.00026422023,0.00006273859],"category_scores_gemma":[0.00003533025,0.00026007424,0.00027923836,0.001009736,0.0009365844,0.000047437396,0.00018130864,0.000605874,0.0000032007497],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0005833518,0.00037460666,0.0019258368,0.005523825,0.00881563,0.000009082329,0.00029467454,0.000012714509,0.000011808297,0.0019378619,0.00013109337,0.9803795],"study_design_scores_gemma":[0.00032268107,0.0005658869,0.00031634083,0.0012403876,0.0070629856,0.00003516588,0.00016751065,0.00001397663,0.000005615921,0.000039389375,0.99006915,0.00016088877],"about_ca_topic_score_codex":0.000006583548,"about_ca_topic_score_gemma":0.000088436514,"teacher_disagreement_score":0.9899381,"about_ca_system_score_codex":0.000058136193,"about_ca_system_score_gemma":0.00007661649,"threshold_uncertainty_score":0.99998516},"labels":[],"label_agreement":null},{"id":"W4414947707","doi":"10.1177/17562848251383767","title":"Treatment discontinuation rates due to lack of efficacy through 1 year of maintenance treatment with vedolizumab or subcutaneous infliximab in patients with inflammatory bowel disease: a systematic literature review and meta-analysis","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University Health Centre","funders":"Cilag; Samsung; Celgene; Biogen; Gilead Sciences; United European Gastroenterology; Celltrion; Sanofi; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Vedolizumab; Systematic review; Discontinuation; Infliximab; Inflammatory bowel disease; Ulcerative colitis; Ustekinumab; MEDLINE; Biosimilar","score_opus":0.011456790443229283,"score_gpt":0.28816413606560837,"score_spread":0.2767073456223791,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4414947707","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9666025,0.03040443,0.00065852806,0.00015737895,0.000011731594,0.002039774,0.00010900008,0.000005155406,0.000011488435],"genre_scores_gemma":[0.99367034,0.005075711,0.00034483834,0.00028823278,0.0000037097557,0.00043009032,0.00008325729,0.00001521737,0.00008862321],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99842757,0.00030992698,0.0005289236,0.0003865742,0.0001100006,0.00023697909],"domain_scores_gemma":[0.9990363,0.000037895916,0.0002928728,0.0004673595,0.00011625219,0.00004931145],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0000818117,0.00028562415,0.0010486112,0.00014499215,0.000016255966,0.0000072834405,0.00012607823,0.00004831656,0.000007550192],"category_scores_gemma":[0.00002226956,0.0001619845,0.00014994631,0.00024465343,0.00013885586,0.00002063564,0.000034654728,0.000042252403,3.128809e-7],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.07054234,0.0024512326,0.865526,0.01776078,0.035595763,0.00042627263,0.0010463902,0.0058455006,0.000104546045,0.00027719798,0.0000034839334,0.0004204543],"study_design_scores_gemma":[0.021805353,0.017614534,0.8424087,0.005589332,0.11094194,0.000034261462,0.00026766377,0.00013072893,0.0003426564,0.00009852663,0.0001711747,0.0005950945],"about_ca_topic_score_codex":0.0000030054564,"about_ca_topic_score_gemma":0.00057603687,"teacher_disagreement_score":0.07534617,"about_ca_system_score_codex":0.00006793316,"about_ca_system_score_gemma":0.00006173561,"threshold_uncertainty_score":0.66055363},"labels":[],"label_agreement":null},{"id":"W4415458995","doi":"10.1177/17562848251387501","title":"Dynamic changes in serum alpha-fetoprotein predict prognosis in hepatocellular carcinoma treated with immune checkpoint inhibitors: a systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Therapeutic Advances in Gastroenterology","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Hepatocellular carcinoma; Immune checkpoint; Immune system; Nivolumab; Immunotherapy; Carcinoma","score_opus":0.042061272043501345,"score_gpt":0.29844791246290625,"score_spread":0.2563866404194049,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415458995","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0053435187,0.9796166,0.000044184224,0.0005808388,0.000023002389,0.0142306825,0.000096902324,0.00004825569,0.000016060349],"genre_scores_gemma":[0.14255388,0.845018,0.00018643729,0.0002342989,0.000008887396,0.011501468,0.0002979232,0.0000771093,0.00012195048],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.9929929,0.001902666,0.0024459523,0.0013344199,0.0003628382,0.0009612177],"domain_scores_gemma":[0.99756265,0.00024747566,0.001032633,0.00093072373,0.00008205174,0.00014445877],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.0012192823,0.0012772635,0.01404056,0.0022156169,0.000039605835,0.000023748269,0.0003512124,0.00042570036,0.00009520615],"category_scores_gemma":[0.000043211145,0.00083369645,0.0014506466,0.002135375,0.00023183969,0.00014325077,0.00014981885,0.0008390763,0.000004498903],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002407647,0.00052892923,0.26642603,0.68990695,0.036124133,0.0011308398,0.00008961821,9.5020386e-7,0.0000010622116,0.000002749065,2.0180896e-7,0.0055477507],"study_design_scores_gemma":[0.0028260162,0.0027638462,0.0014404771,0.13622585,0.8544514,0.00044344823,0.00006462363,0.0005085931,0.000018452614,0.00001759562,0.0006273295,0.0006123774],"about_ca_topic_score_codex":0.00014287629,"about_ca_topic_score_gemma":0.0020562129,"teacher_disagreement_score":0.81832725,"about_ca_system_score_codex":0.0005029811,"about_ca_system_score_gemma":0.00014850336,"threshold_uncertainty_score":0.9999979},"labels":[],"label_agreement":null},{"id":"W4416144529","doi":"10.1177/17562848251395566","title":"Integrated analysis of the safety of fecal microbiota, live-jslm in adults with recurrent <i>Clostridioides difficile</i> infection from five prospective clinical trials: an update","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Clostridium difficile and Clostridium perfringens research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary; University of Victoria; University of British Columbia","funders":"","keywords":"Feces; Prospective cohort study; Incidence (geometry); Clinical trial; Fecal bacteriotherapy","score_opus":0.0268993107662846,"score_gpt":0.37459244775640627,"score_spread":0.34769313699012167,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4416144529","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9949908,0.0016946358,0.0011308204,0.00039220558,0.00025265312,0.0012175465,0.00024326197,0.000018326587,0.000059710248],"genre_scores_gemma":[0.9950652,0.004274834,0.00019412756,0.00019310179,0.000046429705,0.000057985755,0.00013750233,0.000016166165,0.0000146191505],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.99454415,0.0023375517,0.0017635571,0.00064584374,0.0002771021,0.00043178487],"domain_scores_gemma":[0.99743575,0.000979277,0.00058727054,0.00062061136,0.00030087607,0.00007619073],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0017748488,0.00030374803,0.001823614,0.00064693595,0.000041510586,0.0000074947566,0.00029698788,0.00020835054,0.000077957215],"category_scores_gemma":[0.00053915026,0.00019480305,0.00039870618,0.0017750558,0.0007202834,0.00010358264,0.00012285632,0.00089000806,0.0000012939959],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.055634703,0.0020285707,0.89882106,0.000080965896,0.0013593211,0.000008793432,0.00043045636,0.00086226786,0.0047569606,0.000059875903,0.000006726933,0.03595029],"study_design_scores_gemma":[0.01217395,0.0042897053,0.9629723,0.0011145942,0.0016924391,0.000006514561,0.0010209207,0.004628558,0.011563192,0.00016386788,0.00022679819,0.00014716358],"about_ca_topic_score_codex":0.00090678624,"about_ca_topic_score_gemma":0.011559062,"teacher_disagreement_score":0.06415123,"about_ca_system_score_codex":0.00030517037,"about_ca_system_score_gemma":0.00022977746,"threshold_uncertainty_score":0.79438376},"labels":[],"label_agreement":null},{"id":"W65908905","doi":"10.1177/1756283x10373176","title":"Review: Anti-adhesion molecule therapy for inflammatory bowel disease","year":2010,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":109,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Calgary","funders":"","keywords":"Medicine; Natalizumab; Inflammatory bowel disease; Inflammation; Vedolizumab; Tumor necrosis factor alpha; Immunology; Cell adhesion molecule; Crohn's disease; Disease; Integrin; Monoclonal antibody; Cancer research; Antibody; Internal medicine; Receptor","score_opus":0.00674600686005434,"score_gpt":0.2736574793723124,"score_spread":0.26691147251225805,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W65908905","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9734003,0.02229296,0.0021832439,0.00042012724,0.0005081334,0.0010618401,0.000034802775,0.00003166778,0.00006690222],"genre_scores_gemma":[0.9595221,0.029364217,0.0005387762,0.009578892,0.00027596505,0.00048296736,0.00013078169,0.000059523143,0.00004674168],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9983046,0.00015381214,0.0003819591,0.000520388,0.00011119528,0.0005280463],"domain_scores_gemma":[0.99892515,0.00002017242,0.0001605391,0.0006374809,0.00008905647,0.0001675959],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00033475677,0.00028195794,0.00023622086,0.00007206872,0.00007098423,0.000009817939,0.0003952086,0.00011836205,0.000044753397],"category_scores_gemma":[0.00007040858,0.0002646834,0.00016790211,0.000041078263,0.00023499127,0.000020291727,0.000077801036,0.00020006044,0.000010585134],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008570008,0.0005370491,0.664439,0.00081911735,0.00009706241,0.00008718185,0.000036860485,0.00023735626,0.31072897,0.0005404059,0.0012930202,0.012613961],"study_design_scores_gemma":[0.009167772,0.001391816,0.6664838,0.00035139345,0.00009822811,0.00004525968,0.000030125266,0.00045876842,0.01022062,0.0024038365,0.30851874,0.00082962203],"about_ca_topic_score_codex":4.697362e-7,"about_ca_topic_score_gemma":0.00005578771,"teacher_disagreement_score":0.3072257,"about_ca_system_score_codex":0.00001230776,"about_ca_system_score_gemma":0.000073233,"threshold_uncertainty_score":0.9999805},"labels":[],"label_agreement":null},{"id":"W7116968462","doi":"10.1177/17562848251403009","title":"Effectiveness of ustekinumab in Crohn’s disease across intestinal locations: spotlight on isolated small intestinal involvement","year":2025,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Department of Education of Zhejiang Province","keywords":"Ustekinumab; Disease; Crohn's disease; Inflammatory bowel disease; Intestinal mucosa","score_opus":0.008374039543015771,"score_gpt":0.2842808799602634,"score_spread":0.27590684041724767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7116968462","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.9824153,0.0008329912,0.015815524,0.00007607026,0.000196436,0.00055108336,0.000019828743,0.000014763036,0.000078009594],"genre_scores_gemma":[0.99874115,0.00012139329,0.00024198806,0.0005465139,0.000021006417,0.00021447448,0.000066343375,0.000019119881,0.000027987982],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9980252,0.00050882605,0.000459227,0.0004790083,0.000089048764,0.00043870145],"domain_scores_gemma":[0.9991732,0.00009040022,0.0001417589,0.0004236291,0.00010243203,0.000068541],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043768523,0.00024572728,0.00027103096,0.0001713927,0.00003832759,0.000008103508,0.00033836009,0.00008175471,0.0000075978073],"category_scores_gemma":[0.00012376558,0.00024507503,0.00007578563,0.00016377943,0.00030757606,0.000012055047,0.00015414282,0.00019336183,0.000003222965],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.027642913,0.0008038785,0.9468925,0.0004710163,0.000057700003,0.0001898883,0.00007511888,0.007992647,0.010207625,0.000882876,0.000003032024,0.0047808187],"study_design_scores_gemma":[0.0031271535,0.00063820585,0.99023163,0.00059191155,0.00002273936,0.000007066519,0.00010448038,0.00070308894,0.0025308896,0.0017467965,0.00016127626,0.00013476558],"about_ca_topic_score_codex":0.000013719304,"about_ca_topic_score_gemma":0.00062118913,"teacher_disagreement_score":0.04333914,"about_ca_system_score_codex":0.00010773198,"about_ca_system_score_gemma":0.00010941894,"threshold_uncertainty_score":0.99938697},"labels":[],"label_agreement":null}]}